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Jacob H. Levine
Recent developments in single-cell measurement technologies have yielded dramatic increases
in throughput (measured cells per experiment) and dimensionality (measured features per
cell). In particular, the introduction of mass cytometry has made possible the simultaneous
quantification of dozens of protein species in millions of individual cells in a single experiment.
The raw data produced by such high-dimensional single-cell measurements provide unprece-
dented potential to reveal the phenotypic heterogeneity of cellular systems. In order to realize
this potential, novel computational techniques are required to extract knowledge from these
complex data.
Analysis of single-cell data is a new challenge for computational biology, as early devel-
opment in the field was tailored to technologies that sacrifice single-cell resolution, such as
DNA microarrays. The challenges for single-cell data are quite distinct and require multidi-
mensional modeling of complex population structure. Particular challenges include nonlinear
relationships between measured features and non-convex subpopulations.
This thesis integrates methods from computational geometry and network analysis to de-
velop a framework for identifying the population structure in high-dimensional single-cell data.
At the center of this framework is PhenoGraph, and algorithmic approach to defining subpop-
ulations, which when applied to healthy bone marrow data was shown to reconstruct known
immune cell types automatically without prior information. PhenoGraph demonstrated su-
perior accuracy, robustness, and efficiency, compared to other methods.
The data-driven approach becomes truly powerful when applied to less characterized sys-
tems, such as malignancies, in which the tissue diverges from its healthy population composi-
tion. Applying PhenoGraph to bone marrow samples from a cohort of acute myeloid leukemia
(AML) patients, the thesis presents several insights into the pathophysiology of AML, which
were extracted by virtue of the computational isolation of leukemic subpopulations. For ex-
ample, it is shown that leukemic subpopulations diverge from healthy bone marrow but not
without bound: Leukemic cells are apparently free to explore only a restricted phenotypic
space that mimics normal myeloid development. Further, the phenotypic composition of a
sample is associated with its cytogenetics, demonstrating a genetic influence on the population
structure of leukemic bone marrow.
The thesis goes on to show that functional heterogeneity of leukemic samples can be com-
putationally inferred from molecular perturbation data. Using a variety of methods that build
on PhenoGraph’s foundations, the thesis presents a characterization of leukemic subpopula-
tions based on an inferred stem-like signaling pattern. Through this analysis, it is shown that
surface phenotypes often fail to reflect the true underlying functional state of the subpopu-
lation, and that this functional stem-like state is in fact a powerful predictor of survival in
large, independent cohorts.
Altogether, the thesis takes the existence and importance of cellular heterogeneity as its
starting point and presents a mathematical framework and computational toolkit for analyzing
samples from this perspective. It is shown that phenotypic and functional heterogeneity are
robust characteristics of acute myeloid leukemia with clinically significant ramifications.
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1.1 Toward quantitative cell biology
We do not merely suggest the application of these new technologies to classical cell
biological questions, but rather that the fundamental approaches of systems biol-
ogy, which are unbiased, large-scale, quantitative and multivariate, are integrated
into the core of molecular cell biology in the future.
— Liberali & Pelkmans [1]
1.1.1 There are no lonely cells in biology
Cellular differentiation is fundamental to multicellular life. Indeed, phenotypic divergence and
functional specialization are so ubiquitous in multicellular populations that they are found
in colonies of unicellular organisms [2]. There is no such thing as a multicellular organism
without cellular differentiation.
The phenotypic and functional heterogeneity generated by cellular differentiation has been
traditionally considered the purview of cell and developmental biology. Perhaps for this rea-
son, progress in this area has lagged behind other branches of the biological sciences. For the
decades of the twentieth century during which molecular biology flourished, cellular hetero-
geneity may have seemed not only tangential to central questions but perhaps counterpro-
1
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Figure 1.1: β-galactosidase activity measured in bulk aliquots taken at regular intervals from
a chemostat with a fixed concentration of inducer. Reproduced from [3].
ductive. Many molecular biology laboratory techniques produce an aggregate measure for an
entire population (e.g., culture, tube, plate, specimen), collapsing any cell-to-cell variation
into a single point estimate (e.g., mean value). A concrete example is lysis, which is used
commonly to extract and purify molecular components such as DNA, RNA, or protein. Lysis
is used out of pragmatic necessity to obtain sufficient material for further analysis. By pool-
ing the contents of each individual cell, the lysate physically produces an average quantity
and renders the cellular heterogeneity of the sample inaccessible. The experimentalist who
needs lysis for his or her protocols would prefer that the cellular heterogeneity it destroys is
negligible.
On the contrary, cellular heterogeneity is far from negligible and this fact is not new,
though it may have been forgotten. Ironically, one of the clearest examples of cellular het-
erogeneity and the importance of preserving single-cell resolution comes from an early study
of the lac operon, a fundamental model system of molecular biology [4]. The lac operon
is a genetic regulatory system of the bacterium Escherichia coli that controls production
of several enzymes in response to lactose, including β-galactosidase, which enable its use as
an energy source. In their 1957 study, Novick & Weiner [3] investigated the kinetics of β-
galactosidase production in response to an inducer.1 Using a method that measures aggregate
β-galactosidase activity in vitro, enzyme production appears to rise linearly upon induction
1Specifically, the nonmetabolizable lactose analogue thiomethyl-β-D-galactoside (TMG).



















Figure 1.2: Alternative schematic depictions of distributions of β-galactosidase expression by
single E. coli cells during induction of the lac operon as studied in [3]. The vertical dotted
lines indicate the (identical) population means, measured by the aggregate enzyme activity
assay. In (b), the mean identifies a cellular state that is vanishingly rare in the distribution.
and taper off as a saturation point is reached (Figure 1.1). One might be tempted to conclude
that after induction, each cell increases enzyme production until all cells are producing at full
capacity. However, as the authors observed:
Whenever kinetic experiments are performed using bacterial cultures, the question
must be raised whether the results obtained represent the events occurring within
the individual cell or some average of a heterogeneous population. (p. 559)
They went on to show that every E. coli cell exists in one of two discrete states: induced
(producing β-galactosidase at the maximum rate) and uninduced (producing essentially no
β-galactosidase). The appearance of intermediate production rates is nothing but an artifact
of averaging over a heterogeneous distribution of cellular states by the aggregate assay. In
this case, the aggregate measurement was highly misleading, implying that the majority of
cells exist in a state that is in fact vanishingly rare (Figure 1.2).
1.1.2 A century of single-cell analysis
Novick & Weiner used the term single-cell analysis in reference to the dilution experiments
that allowed them to infer the induction state of individual cells in a parent culture. At
the time, those methods and the corresponding term were rarely used in biology (Figure
1.3). Instead, the majority of research in cell biology was conducted by microscopy, which
CHAPTER 1. INTRODUCTION 4















Figure 1.3: Frequency of the 3-gram “single cell analysis” in the corpus of books digitized by
Google (https://books.google.com/ngrams).
inherently preserves single-cell resolution.
Microscopy
The invention of the microscope was the founding event of cell biology, usually attributed to
van Leewenhoek and Robert Hooke in the seventeenth century. In the nineteenth century,
biologists such as Theodor Schwann turned the microscope to animal tissues. At the start of
the twentieth century, the study of individual cells under the microscope was the state of the
art for biological science.
The term cell type emerged from the descriptive analyses of early microbiologists, who
began to classify cells based on a variety of features observed under the microscope including
morphology2, staining reactivity3, and functional behaviors.4 It is worth noting that a great
deal of early descriptions of cell types come from studies of the immune system, perhaps
because this system is the interface of the multicellular organism with the microbial world.
To cite an ordinary example, a 1905 edition of the Journal of the American Medical Association
2Often nuclear morphology, e.g., megakaryocytes [5]
3e.g., Ehrlich’s neutrophil granulocytes
4e.g., Metchnikoff’s phagocytes
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included an article describing the human immune response to pathogen exposure, which began
with this summary:
Cell Types—If leucocytes [sic.] consisted of but a single variety of cells, with
common functions, the study of leucocytosis would be reduced to a simple pro-
cess. It would then be sufficient simply to ascertain the degree of leucocytosis by
estimating the total number of leucocytes to a cubic millimeter of blood. It is well
known, however, that the white blood corpuscles consist of several more or less
distinct varieties. ([6])
The author went on to emphasize (and demonstrate anecdotally) that the composition of the
immune response—the proportions of the various cell types induced by the pathogen—can
indicate prognosis in human disease.
As is well known, in the mid-twentieth century biological research was dominated by
studies of the molecular components of the cell, using biochemical techniques to reveal their
properties. As mentioned previously, these biochemical techniques typically traded single-cell
resolution for experimental tractability, pooling together the molecular pieces of disintegrated
cells in order to obtain sufficient material. Hence the need later to explicitly designate “single-
cell” methods as such. In the broad history of biological sciences in the twentieth century,
single-cell analysis began at the forefront and, after receding for several decades, reemerged in
the 1970s after several methodological developments led to the era of immunophenotyping.
Immunophenotyping
The reemergence of single-cell analysis was spurred by the advent of flow cytometry in
the 1960s, an ingenious introduction of fluidics into cell biology. Flow cytometry preserves
the integrity of single cells by injecting them into a narrow laminar fluid stream, allowing
individual measurement as each cell passes serially through a detection chamber. In the late
1960s, the technology was elaborated to incorporate fluorescence optics such that the staining
intensity of a fluorescent dye could be quantified in each cell. The method was further extended
by Herzenberg et al. in the early 1970s to include electromagnetic control of the fluid stream,
CHAPTER 1. INTRODUCTION 6
permitting the physical sorting of cells based on their measurements—a technology known as
fluorescence-activated cell sorting (FACS) [7]. FACS technology was immediately deployed
to characterize cellular heterogeneity in the immune system, using functional assays of sorted
populations to characterize cell types and obtaining the composition of peripheral blood from
the cell counts recorded by the cytometer [8]. Thus, a striking continuity exists from the work
of early microscopists to the immunologists of the 1970s, with the taxonomy of hematologic
cell types and the cellular composition of blood being constant objectives.
In order to use flow cytometry or FACS to any advantage, it is necessary that a biologically
interesting feature can be coupled to fluorescence intensity. For example, staining DNA by
bromodeoxyuridine incorporation or Hoechst dye provides a means to couple fluorescence
intensity to DNA content [9]. To uncover the diversity of cell types more comprehensively,
probes with greater specificity are required—ideally, probes that can label the distinct proteins
by which distinct cell types manifest. Precisely this capability was provided by the advent
of hybridomas in 1975 [10], which transformed the methodological possibilities for single-cell
analysis. Created by fusing antibody-producing B cells with myeloma cells, hybridomas are
essentially monoclonal antibody factories, an unlimited source of protein-specific tags that
can be chemically conjugated to detectable stains such as fluorophores. The availability of
hybridomas effectively turned the immune systems of allospecific animals into laboratory
reagents.
It was quickly appreciated that monoclonal antibodies specifically label different subsets of
cells whose functional distinctions could be demonstrated by in vitro assays following FACS.
By 1984, an international protocol for antibody nomenclature was established (using the “clus-
ter of differentiation” [CD] system), formalizing the use of antibodies as laboratory reagents
[11].
“Immunophenotyping” refers to the use of antibodies as mediators of protein-specific stain-
ing and thereby measuring the phenotypes of individual cells. An immunophenotype is usually
reported in terms of the CD nomenclature: for example, a CD3+/CD8+ cell is “positive for”
(i.e., expresses) the antigens to which CD3 and CD8 antibodies bind. From functional studies,
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Figure 1.4: Schematic depiction of some
immune cell types and CD antigens
that distinguish them. Source: https:
//commons.wikimedia.org/wiki/File:
Cluster_of_differentiation.svg
we know that a cell with this particular immunophenotype is a cytotoxic T cell. A very basic
schematic of immune cell types, highlighting characteristic CD immunophenotypes, is shown
in Figure 1.4. Note that 10 different CD markers are used to distinguish these cell types;
some markers (CD4, CD8, CD25) provide fine distinctions within a parent group defined by
other, more broadly expressed markers (CD3, CD45).
Fluorescence-based cytometry and CD reagents co-developed for three decades, dramat-
ically expanding knowledge about cellular phenotypes. As the “bank” of designated CD
reagents grew, so too did the repertoire of fluorescent tags that could be used to detect them.
As different fluorophores have different excitation and emission spectra, the use of multiple
lasers (for excitation) and filters (for detection) allowed cytometers to measure multiple CD
antigens simultaneously in single cells. By the end of the twentieth century, cytometers were
capable of measuring 11 distinct fluorophores simultaneously [12]. The addition of more and
more dimensions to the technology was driven by the recognition that each dimension reveals
another facet of phenotypic complexity, each with the potential to disclose vital information
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about the system under study. For example, De Rosa et al. [ibid.] showed that naive T
cells (defined by functional assays) could be weakly enriched by a single marker (CD45RA)
and were only completely purified when a combination of 5 markers was used. In general,
the number of resolvable subpopulations grows geometrically with the number of measured
dimensions.5 Obtaining fine-grained resolution of the population structure by measuring cells
in multiple simultaneous dimensions may be critical for getting an accurate “census” of a
multicellular population [13]. As mentioned above in reference to Figure 1.4, measurements
of CD4, CD8, and CD25 in addition to CD3 are critical for establishing even a coarse-grained
understanding of the T cell composition in a hematologic sample.
The availability of multiple fluorophores and the ability to mix and match them with dif-
ferent antibody probes allows the design of multivariate staining panels. Such panels spurred
massive growth in the popularity of flow cytometry and FACS for research as well as clinical
disease diagnostics and monitoring [14]. Fluorophores have been the blessing and the curse of
antibody-based protein detection: making multivariate detection possible while also setting
a restrictive upper limit on the number of proteins that can be measured simultaneously.
The characteristic wavelengths at which a given fluorophore absorbs and emits light are not
precise values but rather broad distributions over the electromagnetic spectrum (Figure 1.5a).
Loading a panel with multiple fluorophores inevitably leads to spectral overlap, which can
make it difficult or ultimately impossible to determine which fluorophore generated the light
detected at a given wavelength: the signal is confounded. The problem can be ameliorated
somewhat by compensation, a linear transformation of the data that removes the correla-
tion between fluorophores expected from spectral overlap. After proper compensation, the
number of simultaneous features that can be measured is nevertheless limited by the number
of windows in the electromagnetic spectrum where the signal from one fluorophore is greater
than the sum of emissions from the remaining fluorophores on the panel. Flow cytometry is
generally limited to ∼ 12 fluorophores in practice, with higher numbers being possible but
requiring that any given cell express a sparse subset of target proteins and that these sparse
5Provided they are not redundant, each additional dimension splits the cells into at least two additional
subpopulations.
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(a) Fluorescence spectra for 12-color FACS [13] (b) Mass spectra for 30-isotope mass cytometry [15]
Figure 1.5: Fluorescence versus mass spectra. While spectral overlap limits the number of
colors that can be used in fluorescence cytometry, mass spectra are generally non-overlapping
peaks, eliminating the “crowding” problem associated with fluorescence-based methods.
combinations be known in advance so the panel can be designed accordingly.
Mass cytometry
While 12-color fluorescence cytometry is useful, the limitation begs the question whether other
technologies can pick up where fluorescence leaves off, in terms of dimensionality. Indeed, in
recent years a technology was introduced that uses transition element isotopes (not normally
found in biological samples) as chelated antibody tags in place of fluorophores. Like fluo-
rescence cytometry, mass cytometry uses a fluid stream to feed single-cell droplets serially
into a detector. Instead of an optical detection chamber, mass cytometry uses a time-of-flight
(TOF) mass spectrometer to quantify elemental ions present in each single-cell droplet after
ionization by a 5500 Kelvin plasma [16]. This technology takes advantage of the high sensitiv-
ity of mass spectroscopy for isotopic analysis, resulting in essentially no overlap between the
mass tags. Therefore, unlike the “crowding” of fluorophores in the electromagnetic spectrum,
atomic mass tags do not run out of space (Figure 1.5b). Instead, the dimensionality of mass
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cytometry is bounded by the range of masses for which enriched stable isotopes are available
and that can be detected with comparable sensitivity: this range has extended from 30 to 45
in practice and has been forecast to reach 100 [15, 17].
While mass cytometry has at least threefold greater dimensionality than fluorescence cy-
tometry, it is worth extra emphasis to note that the absence of spectral convolution changes
the practical nature of collecting multivariate single-cell data. Designing a polychromatic
fluorescence panel can be an arduous task, requiring many stages of optimization, due to
the complex excitation and emission spectra of each fluorophore. It is recommended that
fluorescence cytometry experiments include both positive and negative controls for each ac-
quired feature. Positive controls measure each fluorophore in isolation in order to quantify
its independent spillover into each acquisition channel—such controls provide the empirical
“spillover matrix” that is used to compensate the data. Unfortunately, this is already an
imperfect control because the spillover coefficient is not constant across the dynamic range of
the instrument [18]. To account for imperfections in compensation and further spectral con-
taminations caused by dye-dye interactions and cell-dye interactions, negative controls should
also be collected, in which every marker except one is included. These fluorescence-minus-one
(FMO) controls should be generated for each marker—thus, for a D-dimensional fluorescence
panel, 2×D controls should be collected every time data are acquired. The amount of work
required to optimize a particular panel configuration is a significant barrier to panel redesign.
On top of the experimental burden, there is no established way to use the FMO controls
quantitatively—they are typically used to draw manual “positive/negative” gates as part of
a fluorescence cytometry data analysis workflow that is almost always qualitative.
On the other hand, mass cytometry not only provides increased dimensionality but also
produces data that are more appropriate for quantitative analysis. There is no equivalent of
autofluorescence and interaction between mass tags is not a significant factor in panel design.
These facts eliminate the need for marker-specific controls. Further, mass cytometry allows
the inclusion of pure-isotope beads that can be used to standardize measurements acquired
at different times [19]. Finally, the dimensionality allows for sophisticated barcoding systems
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that enable multiplexed acquisition, which further increases quantitative comparability and
reduces reagent usage [20]. Thus, mass cytometry panel (re-)design is more straightforward
and flexible compared to fluorescence cytometry. These features encourage high-throughput
production of single-cell data that are quantitative and multivariate, increasing both the need
and the potential yield of computational analysis.
Over the last century, scientific descriptions of cellular phenotype have evolved from quali-
tative descriptions to quantitative high-dimensional measurements. As the data type changes,
so too do the analytical possibilities for answering perennial questions relating to the types
and composition of multicellular populations.
1.2 Learning cell types from experiment
1.2.1 Immunophenotyping normal hematopoiesis
It had been known before the development of immunophenotyping techniques that human
bone marrow contains colony-forming cells capable of giving rise to progeny of differentiated
lineages [21, 22]. In the 1980s, it was discovered that human bone marrow progenitor cells ex-
press the membrane antigen CD34 [23]. Using 3-color FACS, it was discovered that immature
bone marrow cells begin to express markers of lineage commitment only after CD34+ cells
begin expressing another marker, CD38, implying that progenitors with a CD34+/CD38−
phenotype might represent the apex of hematopoietic development [24]. Indeed, using the
sorting capability of FACS, it was shown that CD34+/CD38− bone marrow cells are more
efficient at forming colonies in vitro and display morphological features consistent with an
undifferentiated state.
To study cell types by FACS, cells are sorted by setting rules that define ranges of values
for each dimension, dividing the population into gates jointly satisfying each rule. For ex-
ample, Figure 1.6 shows the gates used in [24] to enrich for hematopoietic stem cells (HSCs).
All FACS experiments employ a “guess and check” design: Gates must be defined at the
time of sorting (guess) and functional validation is performed after sorting (check). Thus,
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Figure 1.6: An example of FACS gates used
to identify hematopoietic stem cells in hu-
man bone marrow [24]. The box labeled
“PI” represents a region of the bivariate
space where cells are CD34+/CD38−. Cells
falling into each gate were separated by
FACS and submitted to functional analysis.
learning about cell types from FACS experiments requires that the system under study pro-
duce a predictable array of phenotypes, allowing the prospective definition of gates based on
prior knowledge. Indeed, normal bone marrow displays remarkably predictable phenotypes,
allowing prospectively defined gates to isolate the same cell type universally across individu-
als. Progress in learning about cell types from FACS experiments has relied heavily on this
predictability.
1.2.2 Immunophenotyping malignant hematopoiesis
As was the case for healthy human bone marrow, it had been known before the introduction
of immunophenotyping techniques that leukemic bone marrow also contains colony-forming
cells capable of generating differentiated progeny. Unlike the colony-forming cells of normal
marrow, however, leukemic marrow tends to form cells of a specific lineage and this can
actually be used to define the various types of leukemia. For example, acute myeloid leukemia
(AML) is marked by an overabundance of undifferentiated leukocytes (also called “blasts”)
that resemble myeloid progenitors and can produce differentiated myeloid progeny, with the
extent and type (monocytic, granulocytic) of differentiation depending on the individual case.
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AML as a deregulated tissue
It has been hypothesized since at least the 1970s that AML arises from a disruption in nor-
mal myelopoiesis—a “differentiation block” causing cells which would be otherwise destined
for myeloid fates to accumulate in an undifferentiated state. Indeed, there is experimental
evidence that at least forms of AML are caused by disruption of the mechanism regulating
the passage of cells from an immature to a mature cell type. For example, some AML blasts
can be induced to differentiate into macrophages and granulocytes (both in vitro and in
vivo) by cytokines called colony-stimulating factors (CSF); following exposure to CSF these
leukemic blasts follow the same series of morphological events as observed in normal myeloid
maturation, including terminal exit from the cell cycle [25, 26]. Unlike their normal coun-
terparts, these leukemic blasts proliferate rather than die in the absence of CSF, linking the
differentiation block to enhanced proliferation.
The demonstration that all-trans-retinoic acid (ATRA) induces terminal differentiation of
acute promyelocytic leukemia (APL; a subtype of AML) and the subsequent clinical trans-
formation of APL from the most fatal to the most curable form of acute leukemia must be
regarded as one of the greatest successes in the history of translational medicine [27]. It
proves that at least one form of AML is caused by a differentiation block that, when lifted,
allows cells to stop proliferating and resume normal development. Unfortunately, the clinical
success of ATRA for APL relies on a specific fusion protein involving the ATRA receptor,
which occurs in the overwhelming majority (95%) of APL cases [28]. Thus, the clinical benefit
of ATRA is not applicable to other forms of AML, unfortunately.
A “molecular lever” to control cellular differentiation in other forms of AML has been
much more elusive. However, genetic and cancer-genomic studies have revealed a common
molecular pathway that provides mechanistic insight to normal myelopoiesis and AML patho-
genesis. Specifically, the family of transcription factors CCAAT/enchancer binding protein
(C/EBP ) have been implicated as major regulators of lineage commitment and differenti-
ation in normal hematopoiesis [29]. It has been shown in genetically engineered mice that
disruption of C/EBPα blocks the transition from common myeloid to granulocyte/monocyte
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progenitor, resulting in accumulation of myeloid blasts in the bone marrow [30]. C/EBPα
is also clearly a target of the genetic alterations that drive AML: the gene itself is mutated
in a significant number of cytogenetically-normal AML genomes, and other common genetic
abnormalities of AML—such as the AML-ETO1 fusion [t(8;21)] and FLT3-internal tandem
duplication (ITD) mutation—result in downregulated expression of C/EBPα transcript or
decreased post-translational activation of C/EBPα protein [31]. Finally, it has been shown
that another member of this gene family, C/EBPβ, is strongly activated by ATRA in APL
cells and that this activation is required for ATRA-mediated differentiation to occur [32]. A
hallmark of a true cancer driver is that different cases utilize different mechanisms to realize
the same outcome at the pathway level. It is clear that AML uses a variety of proximate
causes to prevent myeloid differentiation via inhibition of C/EBP transcription factor activity
[28].
Leukemic “cell types”: The CSC model
Perhaps because AML is a deregulated myelopoietic process, it retains much of the hierarchical
structure of normal hematopoiesis despite its malignant behavior. It has been recognized for
decades that most cases of AML are composed of phenotypically distinct subpopulations that
vary in their potential for self-renewal, proliferation, and differentiation [33–35]. Given the
similarity exhibited by AML to the structural organization of cellular potential in normal
bone marrow, it is logical to hypothesize that AML immunophenotypes reflect the functional
features of analogous subpopulations in normal bone marrow.
It was in the context of AML that the cancer stem cell (CSC) model was developed. In
1997, it was first shown in vivo that CD34+/CD38− human bone marrow cells are dramatically
enriched for HSCs, which are capable of engrafting and reestablishing the immune systems
of nonobese diabetic/severe combined immunodeficient (NOD/SCID) mice [36]. That same
year, it was reported by the same group [37] that CD34+/CD38− leukemic marrow cells
are similarly enriched for cells that engraft and propagate AML in NOD/SCID mice. This
demonstration that only a subset of leukemic cells are capable of “seeding” new malignancies
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implied that these cells are leukemic stem cells (LSCs). Though it was initially reported that
only CD34+/CD38− cells are LSCs, subsequent studies using more sensitive assays identified
CD38+ [38] and CD34− [39] LSCs, overturning the initially proposed LSC model.
While the CSC model has been questioned wholesale in some cancer types, it remains well
supported that most cases of AML do exhibit a functionally differentiated hierarchy—i.e.,
only a subset of blasts can propagate the malignancy and these cells give rise to progeny that
both possess and lack this capability [40]. Furthermore, it has been shown that estimates
of LSC frequency are correlated with chemoresistance and poor overall survival [41, 42],
corroborating not only the existince of LSCs but also their clinical significance. However, a
consistent immunophenotype that can prospectively isolate this subset of cells across patients
has not been forthcoming [43].
It should perhaps be expected that LSCs do not present the same immunophenotype across
patients. After all, most CD antibodies target membrane-bound proteins that are correlated
with—but not causal for—cellular function. Many common CSC markers, including CD34,
are primarily involved in cell adhesion6 rather than functions more closely related to stem cell
identity [44]. CD34 is certainly not necessary for HSC function in general, given that murine
HSCs are specifically negative for mCD34 [45]. That these surface markers may be used
as proxies for cellular function in normal hematopoiesis—universally, across individuals—
is a testament to the exquisite coordination of protein expression in healthy tissues. Such
coordination should not be expected in malignancy, driven as it is by deregulation.
Thus, passive monitoring of surface antigens is not sufficient to identify the important
aspects of intratumor heterogeneity. Reporters of functional potential should be preferred, as
each unique malignancy may locate functional potential in different phenotypic compartments.
The question then arises what to use as a functional reporter. One option is the xeno-
transplantation assay, which requires sorting every tumor into prespecified gates via FACS
and estimating LSC frequency via limiting dilution assays, which requires injecting tumor
cells into several mice per gate. In fact, this approach was taken by one group, whose results
6Which raises legitimate concerns about biases imparted by the xenotransplantation assay, but which is not
the main issue I wish to stress here.
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will be discussed at length elsewhere [43]. Another option is to measure the quantitative
activation of proteins that participate in cellular signaling cascades, using antibodies that
specifically target phosphorylated epitopes [46]. It stands to reason that the signaling pro-
file of a cell—the activation status of its various signaling pathways—is intimately connected
with its functional potential [47].
1.2.3 Immunophenotyping in higher dimensions
It is worth considering the importance of dimensionality for learning about cell types, espe-
cially in less characterized tissues. The human proteome generates cellular diversity through
the regulated expression and modification of thousands of protein species across tissues and
developmental stages [48–50]. As mentioned previously, the reliability of low-dimensional
phenotypes such as CD34+/CD38− for defining cell states is a result of the exquisite regu-
lation of protein expression that couples these surface markers to functional state in healthy
tissues. Even cells defined by this bivariate phenotype are a heterogeneous population: Only
a fraction of CD34+/CD38− cells are HSCs (for example, [24] report that 25% of these cells
form primitive colonies in vitro). There are probably other, currently unknown, phenotypic
features (possibly not surface antigens), that if added to form a higher-dimensional phenotype
would define HSCs with greater (possibly 100%) accuracy. Similarly, adding dimensionality
to the definition of LSC enhances the possibility of producing a definition that can be applied
across individuals.
Critically, the benefit of increasing dimensionality is not simply derived from increasing
the likelihood of finding a single essential marker. On the contrary, the benefit comes from
representing cell states as high-dimensional patterns of protein expression and activation,
which are potentially robust to variation in any particular marker. In other words, it is very
rare that a discrete biological function can be attributed to an individual molecule; rather,
biological functions arise from interactions among multicomponent molecular modules whose
activities would manifest as distinct patterns in high-dimensional measurements of the cell
[51].
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Figure 1.7: The number of possible marker combinations as a function of measurement di-
mensionality.
1.3 Learning cell states from data
Computational biology was born of necessity not only to organize the very high-dimensional
measurements generated by new genome wide technologies at the start of the twenty-first
century, but to actually extract knowledge from these overabundant data. Because DNA
sequence is (typically) unchanged between individual cells within a sample, it is safe to regard
each cell as an interchangeable source of DNA molecules, a critical mass of which is required
to actually generate genomic sequence reads. Thus the earliest genomic data were generated
from lysates of multicellular populations. As genomic technologies moved to quantify gene
expression through mRNA abundance, the use of multicellular lysates became problematic.
Unlike gene sequence, gene expression may vary drastically between cells within a sample. Yet,
bulk measurement of cells through whole-sample lysis collapses this intercellular heterogeneity
into a single (average) measurement (similarly, for example, to what is depicted in Figure 1.2).
Though these bulk lysates are not ideal for understanding gene expression in heterogeneous
populations, they were technologically necessary for many years. Only very recently have
technologies emerged that provide genome wide quantification of mRNA in individual cells
at a scale that can properly reveal the full distribution of gene expression in a heterogeneous
population [52].
Simultaneously, experiments focused on preserving and exposing cellular heterogeneity
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have gradually increased their dimensionality and only recently entered the quantitative do-
main, as outlined in the previous section. In early FACS experiments, population heterogene-
ity was characterized manually by the experimentalist through exploration of bivariate scatter
plots (like the one shown in Figure 1.6). During the growth of dimensionality that occurred
over the last 30 years, manual exploration of FACS data has become intractable (Figure 1.7).

















= 435 scatter plots to study, per sample. Even a very motivated individual
will be unable to extract the most from the data because patterns in 30-dimensional space
simply cannot be discovered by sequential examination of 2-dimensional subspaces. Thus a
computational approach is needed, not only to aid in handling the overabundant data, but to
extract knowledge that could otherwise never be discovered.
This section introduces concepts and methodological groundwork that will be useful for
performing computational analysis of single-cell data. In particular, we explore the related
concepts of dimensionality reduction and clustering, which are both relevant to the task
of modeling the underlying cell states that produce the variety of high-dimensional cellular
phenotypes measured by new technologies such as mass cytometry.
1.3.1 Terminology
Before proceeding, some terminological subtleties are worth addressing. These distinctions
bring clarity to the discussion and may provide insight for the methods to be presented in
subsequent sections.
We have already encountered the concept of cellular phenotype multiple times. A cel-
lular phenotype is simply any observable trait of a cell. “Immunophenotype” refers to the fact
that a trait has been observed by antibody labeling.7 A cellular phenotype can be an individ-
ual trait or a concatenation of traits: Any of {CD45+, granular, CD15+, CD45+/CD15+} is
a cellular phenotype. For D-dimensional cytometric data, the vector of D staining intensities
7The “immuno-” prefix is often dropped because the use of antibody labeling is so common and because it
is often clear from context, especially when the CD terminology is used.
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generated by each cell may be regarded as its phenotype: After all, this is precisely what is
known about the observable traits of that cell.
Cell state refers to something more abstract. The term has a wider scope than “phe-
notype” and has functional connotations as well. For example, mitosis is a cell state. If
cell cycle markers are measured, a number of phenotypes would reflect mitotic cells. “Cell
state” may also refer to functional potential, as multipotent describes the ability to produce
daughter cells that reach different fates. Because cell states arise in different contexts and
reflect the functional outcome of complex molecular systems, one can expect that a diverse
but restricted set of phenotypes correspond to a cell state. From a modeling perspective, cell
states are latent variables: unmeasured (or unmeasurable) attributes of the cell that can be
inferred from patterns they generate in the observable phenotypes. For an extreme example,
Novick & Weiner inferred that “lactose induction” (a cell state) is an all-or-none phenomenon,
based on the pattern of β-galactosidase activity (a phenotype).
As mentioned previously (§1.1.2), the term cell type emerged in the qualitative descrip-
tions of early microscopists. The term implies functional specialization associated with mul-
ticellular organization: examples include skin cell, muscle cell, nerve cell. Upon closer exami-
nation the term becomes slippery, as it depends on a desired resolution (e.g., nerve cell names
a wide variety of neural cell types) and implies a discretization of developmental processes
that may in fact be continuous [53]. Taking these provisos into account, “cell type” implies
significant phenotypic and functional stability over time, achieved perhaps through epigenetic
regulation [54]. The stability of a cell type might exceed the time scale of a cell state: For
example, a T cell can exist in different states (mitotic, activated) while maintaining its “iden-
tity” as a T cell. The stability of a cell type may also preclude the accessibility of certain
states: T cells cannot produce insulin. One can expect that a diverse but restricted set of
phenotypes and states correspond to a cell type.
Every cell has some (set of) phenotype(s) and exists in some (set of) state(s). Whether
every cell can be regarded as an instance of a cell type is perhaps an open question, especially
in the context of disease.
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A population is heterogeneous when it contains cells in one of several states (and/or
of multiple types). For each state, the cells in that state form a phenotypically coherent
subpopulation—i.e., the cells in that subpopulation are phenotypically more similar to each
other than they are to cells of other subpopulations. In some contexts, it may be convenient
to refer to a subpopulation phenotype. This abuse of terminology might be taken as
shorthand for “the distinctive traits shared by most cells in a subpopulation.” It may also
be used in reference to a D-dimensional vector computed on the cells of the subpopulation
and meant to represent their collective attributes, such as the average expression in each
dimension.
1.3.2 Cluster analysis
Since cytometry became a multidimensional measurement technology, it has been apparent
that subpopulations could be identified as clusters of cells with similar phenotypes. For
example, in 1991, Terstappen et al. wrote:
Multidimensional flow cytometry permits quantitative identification of distinct
cell populations in the heterogeneous blood and BM [bone marrow] aspirates. In
a multidimensional space created by simultaneous measurement of independent
parameters, cell populations with dissimilar properties emerge at different posi-
tions as clusters of cells.8
Though they did not do so, this intuition can be formalized and the task of identifying
subpopulations can be treated algorithmically.
First we consider a highly idealized scenario. First, suppose there is a “complete” mea-
surement space that includes every feature that can possibly contribute to cell state: the
abundance and activation of every protein species, the spatial location of every molecule, et
cetera. Let there be D̃ such features. Suppose there is a technology that measures each of
these D̃ features in each cell sampled from a multicellular population. Suppose that this
8Note that these authors use the term “population” in the sense of “subpopulation” as defined in §1.3.1
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multicellular population is heterogeneous, comprising exactly K cell states each present in
some fixed proportion φk,
∑K
k=1 φk = 1.
When N cells are measured, the output of the technology is a N × D̃ matrix (equivalently,
a set of N D̃-dimensional vectors). If the biological system is noiseless, then each cell state
is present as bφkNe identical cells. If the measurement technology is also noiseless, then the
N × D̃ matrix can be equivalently represented by K sets, each containing bφkNe identical
D̃-dimensional vectors. In this case, the sets of identical vectors trivially identify the K cell
states.
Of course, reality is barely a crude approximation to this hypothetical. Despite the sub-
stantial advances outlined above (§1.1.2), we have not reached the asymptotic “complete”
measurement space. In an incomplete measurement space, there is always the possibility that
an unmeasured variable defines distinct cell states that will be irresolvable in the data. On the
other hand, the number of potentially resolvable cell states increases with each added dimen-
sion, suggesting that it should always be valuable to seek new cell states in data of increasing
dimensionality. Further, due to the modular organization of the cell’s physical and regulatory
systems [55, 56], it is reasonable to expect many dimensions of the complete measurement
space to be redundant and therefore that the intrinsic dimensionality of the cell is less than
D̃ (see §1.3.3).
The hypothetical postulates regarding noise are even further from reality. Stochasticity
is inherent in molecular systems [57], an inevitable result of fluctuations in transcription and
translation that cells have evolved to buffer and exploit in order to control transitions between
states [58, 59]. Thus, cell states should not be expected to generate sets of identical vectors
in real data, even in the absence of measurement noise. Instead, cell states will generate
densities: regions of the measurement space containing a high frequency of similar but
nonidentical vectors. A population composed of K states would generate K different (but
possibly overlapping) densities.
Thus, one may take a statistical view and model the heterogeneous population as a mixture
of densities (also known as a mixture model). This approach has been tried by a number of
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groups for flow cytometry data and will be further discussed in the next chapter (§2.1.1).
Given the foregoing exposition, one might suppose that a mixture of densities would work
quite well to model heterogeneous populations; however, these models suffer from overly rigid
assumptions and computational instability in high dimensions.
A simpler method, which is closely related to mixture models and provides a paradigmatic
example of cluster analysis, is k -means [60]. It is worthwhile to examine k -means in some detail
because it exemplifies how one might formalize the intuitive concept of a cluster. Essentially,
a cluster is a subset of data points that are mutually more similar to each other than they are
to the other data points. A clustering solution assigns all data points to exactly one cluster
such that the overall intra-cluster similarity is maximized. k -means defines both an objective
function that formalizes this idea and an algorithm for optimizing it. The objective function,








where C = {C1, C2, . . . , CK} is a partition of the data X = {x1,x2, . . . ,xN} into K disjoint
clusters and µk is the mean of the data in cluster k, |Ck|−1
∑
x∈Ck x. One can see that (1.1)
formally encodes the notion that a good clustering solution should maximize intra-cluster
similarity: It does so by minimizing the squared Euclidean distance between the cluster’s
centroid and every point it contains. As discussed in the next chapter (§2.1.1), the form of
(1.1) imposes a particular structure on the clusters that may not be desirable in general.
A k -means clustering solution is an arrangement of C that minimizes (1.1). The algorithm
for minimizing (1.1) is a special case of the expectation-maximization algorithm and consists in
iterative updates of C and µk. The procedure is guaranteed to converge to a local minimum;
however, even in simple cases there are numerous local minima that yield poor clustering
results [61, 62]. The problem of finding the global minimum of (1.1) is NP-hard [63]—i.e., it
is computationally intractable9 and therefore heuristics (such as the expectation-maximization
9More precisely, finding the global minimum of (1.1) is in the class of problems believed not to be solvable
in polynomial time (NP) and therefore requires computational resources that scale exponentially with the size
of the data. This prohibitive scaling renders such problems computationally intractable.
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algorithm) must be used in practice to obtain approximate10 solutions. This difficulty is not
specific to k -means; in general, formulations of cluster analysis are NP-complete at best.
Thus, finding “good” clustering solutions necessarily involves designing good heuristics.
Another paradigmatic clustering technique that has been widely used (especially in bioin-
formatics [64]) is hierarchical linkage. Unlike k -means, the approach is entirely heuristic and
provides no global objective function. Briefly, the algorithm begins with every data point
in its own cluster and merges the two most similar points into a new cluster; merging is
repeated hierarchically until the entire data set is merged into a single cluster. Hierarchical
linkage does not explicitly produce a clustering solution but rather a sequence of binary merge
decisions—i.e., a tree. The tree must be post-processed by some heuristic or other (often “by
eye”) in order to extract clusters.
Innumerable variants of these paradigms have been developed over the years. One reason
for this proliferation is probably that—by virtue of the computational complexity—the need
for heuristics introduces domain dependencies. Though no machine learning technique ought
to be used “out of the box” without testing assumptions and integrating domain knowledge,
this proviso is perhaps nowhere more important than in cluster analysis. A clustering method
designed precisely to cope with the various demands of high-throughput high-dimensional
single-cell data is the subject of Chapter 2.
1.3.3 Manifold learning
The irony of high-dimensional data analysis is that while we want to measure as many si-
multaneous variables as possible, we ultimately want to discard as many of these as possible.
More precisely, we seek to reduce them in an information-preserving manner. There are two
reasons: one motivated by the data, the other by the analysis.
From an analytical perspective, each dimension is very costly in terms of the ability
to evaluate structure in the data. There are several ways to demonstrate mathematically
the so-called curse of dimensionality (see, for example, [65] and references therein). The
common theme is that the volume of the measurement space increases exponentially with the
10or exact but not guaranteed to be globally optimal
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Figure 1.8: The joint distribution of two Gaussian variables x and y. In the left panel,
the variables are completely independent. In the middle panel, the variables are moderately
correlated. In the right panel, the variables are perfectly correlated. As the correlation
brings the data onto a lower-dimensional manifold, the sparsity of the measurement space
also increases.
dimensionality; therefore one would require an exponential increase in the number of data
points to maintain a constant sampling rate.11 In other words, high-dimensional spaces are
unavoidably sparse and sparsity is bad for inference.
Compressing linear dependencies
Fortunately, when there are dependencies between the measured variables, the intrinsic
dimensionality is less than the measured dimensionality. A simple example involving two
Gaussian variables, x and y, is shown in Figure 1.8. When the two variables are completely
independent, x provides no information about y and therefore both are required to determine
a point’s location: the data are truly two-dimensional. When the two Gaussian variables are
perfectly correlated (i.e., completely dependent), x provides all information about y (and vice
versa). In this case, the two-variable system has an intrinsic dimensionality of one, apparent
from the restriction of the data to a linear subspace of the (x, y) coordinate system—i.e., a
line. In other words, though the data are embedded in the two-dimensional space R2, they
11For example, suppose that 1,000 data points are sufficient to estimate a distribution in a square (i.e., two-
dimensional hypercube) with constant edge length r. To achieve the same sampling rate in a 20-dimensional
hypercube with the same edge length requires ∼ 108 data points.
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Figure 1.9: PCA extracts uncorrelated latent variables (x̂1 and x̂2, middle panel) from cor-
related variables (x and y, left panel) by applying a rotation. The first principal component,
x̂1, accounts for 90% of the covariance of x and y.
can be re-parameterized by R, the real line.
In the unrealistic case of perfect correlation, the dimensionality can be reduced simply by
dropping one of the variables. In reality, variables display imperfect dependencies, reflecting
either noise or true differences in the variables or both. For example, in the middle panel of
Figure 1.8, neither x nor y would be the best substitute for the other. Instead, the redun-
dancy of these variables should be handled by combining them. This is the approach taken by
latent variable models such as principal component analysis (PCA). The simplest dimension
reduction method, PCA assumes that the observed variables are generated by a linear trans-
formation of (a smaller number of) latent variables and seeks to recover these latent variables
by reverse engineering the linear transformation. In the case of the moderately correlated
Gaussian variables of Figure 1.8, this amounts to a simple rotation such that the first latent
variable (“component”) accounts for 90% of the variance in the data. Projecting the data
into the linear subspace spanned by this single component effectively reduces the dimension
to one (Figure 1.9).
A well-known weakness of PCA is that it can compress only linear dependencies. As
shown in Figure 1.10, rotation and rescaling do nothing to reduce the dimensionality of x and
y when their dependence is nonlinear. Both latent variables x̂1 and x̂2 are needed: Projecting
the data onto the first component x̂1 destroys the structure of the data, despite the fact that
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Figure 1.10: PCA is unable to reduce the nonlinear dependency between x and y. Points are
colored by their order on the line. Rotation and rescaling (middle panel) and projection onto
the first component (right panel) corrupt the structure of the data.
Figure 1.11: Nonlinear relationships between proteins in normal human bone marrow. Cells
are colored by manual gating according to known stages of neutrophilic differentiation. Yellow
and green subpopulations represent the earliest stages of maturation. From [66].
the intrinsic dimensionality of this structure is clearly one.
Compressing nonlinear dependencies
It should come as no surprise that the relationships between variables in single-cell data are
generally not linear (Figure 1.11). The catalog of known biological mechanisms is full of in-
teractions, cascades, feedbacks, and thresholds—all of which generate nonlinear relationships
between the cell’s molecular components. Previous work in our group has shown that linear
dimensionality reduction techniques such as PCA fail to capture phenotypic heterogeneity
while nonlinear methods such as t-Distributed Stochastic Neighbor Embedding (t-SNE) [67]
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are very effective for cytometry data [68].
There are a number of reasons that t-SNE is successful for visualizing single-cell data.
Perhaps the most important reason, and the one most relevant for this dissertation, is that
t-SNE is a distance-preserving method. This class of method is inspired by concepts from
mathematical topology. A central concept in topology is that one can make a distinction be-
tween the structure of an object and its representation in space. An object can be stretched,
twisted, or deformed without fundamentally altering its structure—what matters is the con-
nectivity of points on that object. Technically, this topological object is called a manifold,
which is regarded in distinction to its spatial embedding. Figure 1.12 illustrates the dis-
tinction between a manifold and its spatial embedding. Intuitively, an important feature of
manifolds is that their structure is locally Euclidean. For example, the surface of the Earth
is a two-dimensional manifold (a sphere embedded in physical space R3) that is “flat” on
small scales [65]. The geodesic distance12 between two points in the same city is roughly
Euclidean in R3, which is not true for two points on different continents. In Figure 1.12, the
Euclidean distance between any pair of adjacent (i.e., similarly colored) points is virtually
unchanged across the three spatial embeddings. Conversely, the Euclidean distance between
non-adjacent points can change quite drastically between different spatial embeddings.
With these insights in mind, we can propose that the manifold is the true object of
interest and that the spatial embedding is a necessary but ultimately dispensable way to
learn its structure. Distance-preserving methods begin with the proposition that the data are
generated on a manifold but are embedded in the measurement space RD by an unknown and
generally nonlinear mapping. From this, we can use the corollary that data points which are
adjacent in the embedding space are probably generated by adjacent points on the manifold.
In other words, “any manifold can be fully described by pairwise distances” [65, p. 69]. Given
the set of points in RD and their pairwise distances, the goal of manifold learning is to
reconstruct the manifold by finding a model that is simpler than the data (e.g., of lower
dimensionality) that preserves pairwise distances.
12Literally, the shortest arc between two points on the Earth’s surface, this term may also refer more generally
to the shortest path on any manifold.
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(a) (b) (c)
Figure 1.12: Different spatial embeddings of the same topological manifold. The real line R1
is (trivially) a 1-dimensional topological manifold. Colors represent the intrinsic ordering of
points on the manifold. (a) A subset of the real line is shown embedded in a metric space of
the same dimensionality (the vertical axis contains no information). (b) The same manifold
is shown embedded in R2 as a disconnected circle. (c) The same manifold is shown embedded
in R2 as a disconnected figure eight. Both (b) and (c), but not (a), are nonlinear embeddings
of the manifold in R2.
1.3.4 The phenotypic manifold
Multicellular populations are generated by the articulated processes of division and differ-
entiation. Because daughter cells will generally be very similar to their mother cells, the
phenotypic heterogeneity of the population is established by incremental divergences. These
incremental divergences create restricted paths through the space of possible phenotypes. As
cells are constrained to follow these restricted paths, cellular phenotypes lie on a subspace
of the full high-dimensional phenotypic space. We take the view that this subspace can be
regarded as a topological object, which we call the phenotypic manifold (Figure 1.13). As
such, it may (and does) have a nonlinear embedding in the measurement space. The task of
learning cell states can be translated to the task of learning about the phenotypic manifold.
Modeling the phenotypic manifold is a conceptually motivated approach, rooted in an un-
derstanding of the generative mechanism of cellular populations. As the subsequent chapters
aim to show, it is also an analytically powerful approach, yielding results that are superior to
comparable methods and leading to new insights about cell states in complex tissues.
1.4 Dissertation outline
This dissertation is about two things:
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(a) (b)
Figure 1.13: Schematic depiction of a “phenotypic manifold.” (a) Phenotypic heterogeneity is
generated as cells traverse an “epigenetic landscape,” conceptualized originally by Waddington
[69] and subsequently repurposed by others in the context of modern biology [70]. As cells
(spheres) divide and differentiate, the space of possible phenotypes is structured by regions of
relative stability, represented by grooves in the landscape. The manifold depicted here exists
in two dimensions representing lineage and development, respectively. (b) Cells generated on
the manifold depicted in (a) and measured by a 3-dimensional single-cell technology produces
a nonlinear embedding of the manifold in R3.
(1) Computational techniques for learning cell states from high-dimensional single-cell data
(2) Insights into normal and malignant hematopoiesis obtained from (1)
Chapters 2 and 3 concern different aspects of item (1). Chapter 2 addresses the fundamen-
tal task of subpopulation discovery: Given nothing but single-cell measurements, what are
the distinct cell states reflected in the data? Using the concepts developed above, I detail
an algorithmic solution to this problem and demonstrate its superior performance to other
methods.
Chapter 3 extends the work of Chapter 2 to a more structured setting. Given partial
knowledge about a sample, can this knowledge be extended to categorize the remaining,
unknown portion of the sample?
In Chapters 4 & 5, the methods developed in Chapters 2 & 3, respectively, are applied
to mass cytometry data collected from primary human bone marrow of a cohort of leukemia
patients and healthy donors. Chapter 4 deals with fundamental questions regarding the
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phenotypic composition of these samples, as revealed by the data-driven method introduced
in Chapter 2. Chapter 5 drills into the functional states associated with these subpopulations
and applies a suite of computational techniques—including the content of Chapter 3—to
generate and corroborate inferences about these functional states. Taken together, Chapters
4 & 5 indicate that the immunophenotypes of leukemic blasts often belie their functional state,
the latter of which can be learned by computational techniques and correlate with survival.
Finally, Chapter 6 places the work in a broader context, summarizing what has been
established in the previous chapters and suggesting future directions for learning cell states
from high-dimensional single-cell data.
Chapter 2
Extracting cell states from graphs
of phenotypes
Complex tissues are composed of biologically meaningful subpopulations that are phenotyp-
ically coherent despite the intrinsic variability that makes each cell unique. A fundamental
challenge in quantitative analysis of single-cell data is to establish the major cell states present,
enabling an efficient and meaningful profile of the tissue.
Bone marrow is a common model system for such studies due to the rich diversity of
immune cells found therein, not to mention experimental tractability (e.g., dissociation of cells
into suspension). The wide range of cell types present in bone marrow has been established
by decades of experimental research, which has produced a taxonomy of functionally distinct
lineages (lymphoid and myeloid at the broadest level) and developmentally related progenitors.
While normal immune cells are typically binned into predefined “landmark” cell subsets,
this strategy is unsuitable for less predictable or under-studied tissues such as cancer, where
new phenotypes have been shown to occur [66]. Thus a data-driven, unsupervised approach
is needed that takes single-cell measurements as input and returns a grouping of cells into
distinct subpopulations—i.e., clusters.
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2.1 Related Work
Dimensionality reduction techniques such as t-distributed stochastic neighbor embedding (t-
SNE) [67, 68] help visualize the data but do not explicitly partition samples into distinct
subpopulations. Moreover, while a two- (or three-) dimensional projection is necessary for vi-
sualization, this amount of dimension reduction is not intrinsically desirable. Subpopulations
that are not visually separable in an optimal two-dimensional projection may in fact be distinct
in high-dimensional space, were this requirement to be relaxed. Therefore, clustering methods
which do not seek reduced dimensionality but rather operate in the full-dimensional space may
distinguish subpopulations that appear indistinct even in an optimal two-dimensional projec-
tion.
Several methods have been proposed for clustering single-cell measurements into discrete
phenotypic subpopulations. A thorough comparison of available methods was conducted by
the “FlowCAP consortium” in 2013 [71]. We evaluated the best-performing methods from
this contest, as well as standard clustering methods, and found that they did not perform
well for mass cytometry data. Details of this comparison are discussed below in Section 2.3.
2.1.1 Parametric vs. Nonparametric methods
Clustering methods can be organized into two broad classes.
Parametric methods assume that the data are generated by a mixture of parametric
densities, in which case a clustering solution is obtained by finding parameter values that
maximize the probability of the data. This class of methods, of which the Gaussian mixture
model is the best known (both in general and among cytometry experts [72]), have conceptual
appeal but tend to perform poorly on real data. The parametric densities impose strong as-
sumptions about cluster shape (e.g., ellipsoid, convex, symmetric) which become increasingly
unlikely (and difficult to verify) in high-dimensional space. Attempts to reduce the severity
of these assumptions within the parametric framework do so at prohibitive cost in terms of
tractability and scalability [73]. Even supposing that a parametric model correctly specifies
the underlying distribution, parameter estimation is not robust to noise [74], a pervasive fea-
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ture of any real-world data set. The parametric approach seems particularly undesirable when
one further considers that the measurement space of a single-cell data set generally presents
a nonlinear embedding of the true underlying phenotypes [68].
Nonparametric methods eliminate the assumptions of statistical models by avoiding
these models altogether. Being defined by what they are not (i.e., parametric methods), this
class is more heterogeneous. Typically, nonparametric methods define some objective function
that expresses a ‘good’ clustering solution and seek an assignment of data instances to clusters
such that this function is optimized. k -means is a paradigmatic example. Here, the objective
function (WCSS; Sec. 1.3.2) induces a centroidal Voronoi tessellation (Figure 2.1) in which
clusters are not necessarily ellipsoid or symmetric but are always convex. While weaker than
the other two assumptions, convexity is still a strong assumption about cluster shape—again,
especially in the context of a nonlinear embedding. As a problem, the convexity assumption
can be side-stepped by specifying a large k, since any non-convex set can be broken into
smaller convex subsets. A number of methods developed specifically for cytometry data use
k -means (or similar) to produce a starting point with a large number of small convex sets and
then apply various heuristics to build clusters from these elements by merging [75, 76]. The
trouble with such heuristics is that, lacking principled motivation, they are often unstable and
exhibit sensitivity to small changes in the data, giving inconsistent results even under small
perturbations such as resampling (§2.3).
Spectral methods are a distinctive subclass of nonparametric clustering methods. Sam-
SPECTRAL [77] is one such method developed for cytometry data. Rather than operate
on the data directly, these methods operate on a matrix of pairwise similarities and in so
doing are more closely related to manifold learning (§1.3.3). As such, spectral methods more
successfully handle arbitrary shapes resulting from nonlinear embedding. The downside of
spectral methods is that they can scale very poorly with the number of data points and become
prohibitively expensive in terms of computation. For instance, in [77] the authors estimate
that a standard spectral method, with O(N3) running time and O(N2) memory requirement,
would take 2 years and require 5 terabytes of memory to process a 300,000-cell data set. To
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Figure 2.1: Example of a Voronoi tessellation in two dimensions, reproduced from [65]. The
“+” symbols represent cluster centroids and the red lines identify the Voronoi regions induced
by their locations.
address this problem, SamSPECTRAL deploys a heuristic down-sampling scheme that throws
away data until a ‘representative’ set of 1500−3000 cells (0.5−1% of a 300,000-cell data set!)
is established and clusters are determined from operations on this set.
2.2 PhenoGraph: unsupervised subpopulation discovery
For the new era of high-throughput, high-dimensional single-cell biology, a method is needed
that can robustly identify subpopulations ab initio. Such a method ideally possesses the
following properties:
• Scales favorably with data size (N) and dimensionality (D)
• Handles nonlinear embedding and arbitrary cluster shapes
• Finds clustering solutions that are robust to user-specified input and random resampling
In this section I present a graph-based method that satisfies these requirements.
At the outset, single-cell measurements can be regarded as points in the D-dimensional
space of non-negative real numbers, RD≥0, where D is the number of biological features
measured in the experiment. A sample of N cells can be represented by the N × D ma-
trix X = [x1,x2, . . . ,xN ]. Unsupervised subpopulation discovery is tantamount to clus-
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tering the rows of X, i.e., defining a partition of the N cells into K < N disjoint sets
C = {C1, C2, . . . , CK}.
Due to complex dependencies between the measured covariates, one can expect that the
D-dimensional measurements xi correspond to locations on a lower-dimensional topological
space, P, which we call the phenotypic manifold (§1.3.3). The embedding of P in RD≥0 is not
linear in general.
To learn the phenotypic structure of the sample, we should prefer to handle P rather than
X. For one, the lower dimensionality of P mitigates the analytical difficulties associated with
high-dimensional spaces. More importantly, from a theoretical perspective, the distribution
of points on P reveals the important cell states in the sample. To see this, consider each
individual cell as a dynamical system that is able to traverse P by the coordinated changes
in expression that produce the phenotypic and functional heterogeneity of the population.
Cells that reach robust cell states—defined by their dynamic stability—will tend to stay in
that region of the phenotypic manifold for prolonged durations. Thus, when the population
is sampled, the dense regions of P identify the robust cell states.
We are not able to measure P but we can estimate it from X. A discrete approximation
of P can be constructed by mapping each point in X to a vertex in a graph. Formally, the
graph G = (V,E) is an ordered pair in which V is a set of N vertices connected to each other
by edges in the set E.1 If the edges in E only identify short distances—i.e., only the most
similar points are directly connected—G becomes a discrete approximation of P [65, p. 100].
Thus the work of identifying cell states can be broken into two tasks: 1) constructing G
that approximates P, and 2) analyzing the structure of G to identify dense regions.
2.2.1 Representing phenotypes in a graph
Previous work in our group leveraged the graph representation of a phenotypic manifold to
learn developmental trajectories in B cell lymphopoeisis [53]. In that setting, the task was
not density estimation but rather dimension reduction (to a one-dimensional developmental
1Please note some terminological equivalences that can be found in the literature: {graph ⇔ network ; vertex
⇔ node; edge ⇔ arc ⇔ link }
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axis). In the present setting, the task is clustering and this should motivate the way in which
the graph is constructed. Indeed, G is a dramatically different representation of X and the
quality of the mapping f : X→ G determines how closely G approximates P.
How does one convert a set of multidimensional coordinate vectors to a graph? The
bijective mapping of cells to vertices is straightforward: xi → vi,∀i ∈ {1, . . . , N}. The
question is really how to design the set of edges such that paths through the graph represent
available paths through P—not more and not less. If the graph contains too many edges,
distant regions of P become connected by short circuits and the graph loses its advantages
over the original measurement space. The problem of short circuits is seriously exacerbated
by the presence of noise in the measurements, another challenge that must be addressed by
the graph construction procedure. If the graph contains too few edges, it can fracture into
spuriously disconnected components and information is lost about the structure and density
of points on P. Finally, edges can be binary (present or absent) or they can be weighted, in
which case the weight reflects the strength of the connection between the vertices on either
side of it. The question therefore arises whether edges should have weights and if so how
those values are determined.
As a starting point, there are two simple strategies for converting coordinate data to a
graph: the ε-rule and the k-rule. Both are motivated by the definition of manifold as a
topological space that is locally Euclidean (§1.3.3). This leads to the concept of neighborhood:
at each point x there is a neighborhood of local points V(x) for which the Euclidean metric
is a valid distance metric. If we knew the neighborhood of each point, graph construction
would be trivial: specify edges such that each vertex is connected exactly to its neighborhood.
Instead, we guess by selecting each point’s “nearest neighbors.” By the ε-rule, points falling
within a D-dimensional hypersphere of radius ε are identified as neighbors, Vε(x). By the k-
rule, the k nearest points are identified as neighbors, Vk(x). Both rules require specification of
a parameter that controls the neighborhood size and a distance metric that defines proximity.
The ε-rule is closer in spirit to the motivating concepts of manifold and neighborhood.
However, in practice it is very difficult to select an appropriate value for ε, especially when
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the significance of interpoint distances can vary across different regions of the measurement
space [78], as may very well be true in single-cell data. Selecting an appropriate ε requires a
depth of knowledge about the structure of the data that presupposes the very task for which
graph construction is intended. The k-rule, on the other hand, may lack the conceptual appeal
but is more effective in practice. The procedure adapts to different scales by ranking distances
at each point. The number of neighbors is an intuitive quantity to select compared to the
radius of a D-dimensional hypersphere and provides more direct control over the sparsity of
the graph, which is important for practical applications. However, the k-rule has important
limitations that are relevant for graph clustering. While the k-rule overcomes the variable-
scale problem, it does so at the expense of ignoring differences in local density: every point
selects k neighbors regardless of whether it is at the center of a dense cluster or outlying in a
sparse region.
This problem can be addressed by considering a weighted graph. In a binary graph, the
degree of vertex vi, deg(vi), denotes the number of edges in the graph that involve vi, and
this quantity can be understood as a measure of density at each vertex. This means that the
degree of every vertex in a binary k-neighbor graph is at least k (note that deg(vi) > k when
∃j : xi ∈ Vk(xj) ∧ xj /∈ Vk(xi)). The definition of degree can be generalized for weighted
graphs. Let w : i ∼ j → R≥0 be a weight function that assigns a non-negative weight
to each edge i ∼ j ∈ E and let W denote the N × N weight matrix comprising elements
Wij = w(i ∼ j). Note that for a binary graph w(i ∼ j) = 1, ∀ i ∼ j ∈ E. In general, we can





which, in the case of a binary graph, equals the number of incident edges on vi. For a
weighted graph, deg(v) becomes a more flexible measure of density at each vertex, provided
that edge weights scale with local density. If a weight function satisfies that condition, the
graph combines the desirable properties of the ε-rule and the k-rule.
To define a weight function that scales with local density, consider the relationship be-
tween the density of a region and the k-neighborhoods in that region. Specifically, when two
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points are located in the same dense region, they tend to have neighbors in common—their
neighborhoods will overlap, Vk(xi) ∩ Vk(xj) 6= ∅. On the other hand, if two proximal points





denote the Jaccard coefficient between the k-neighborhoods of cell i and cell j.2 The Jaccard
coefficient quantifies the similarity between two sets and is bounded in the closed interval [0, 1],
reaching the upper and lower bounds when the two sets are identical or disjoint, respectively.
In quantifying the overlap of Vk(xi) and Vk(xj), Eq. (2.2) reflects whether i and j participate
in the same density structure (Figure 2.2). As a corollary, when a point is central to such a
structure, it will have overlapping neighborhoods with a large number of points and the total
edge weight involving that point, deg(v), will be large. Thus Eq. (2.2) provides the desired
scaling with point-wise density (Figure 2.3).
Thus, we define the Jaccard graph as a weighted k-neighbor graph in which edge weights
are given by Eq. (2.2), the Jaccard coefficient between k-neighborhoods. This graph requires
specification of the parameter k, which provides an “initial” estimate of neighborhood size.
As we have seen, the weight function relaxes the influence of k by incorporating the local
data distribution to tune the effective density at each point. As a result of this tuning, the
properties of the graph are robust to the choice of k, as demonstrated in a subsequent section
(§2.3). Importantly, this weighting procedure distinguishes between two very different types
of rare observations: outliers due to noise and genuine rare cell types. While both may occur
at a similar frequency in the data (0.5%, for example), because outliers are generated by
noise, they have few shared neighbors with other points and their overall influence in the
graph is dampened. Conversely, the co-occurrence of genuine rare cells in close phenotypic
proximity results in highly overlapping neighborhoods, which translates to a set of strongly
interconnected vertices, signifying the presence of a robust cell type. Overall, the Jaccard
2It is interesting in the context of this section that the name given by Jaccard for this quantity was le
coefficient de communauté [79].
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(a) (b) (c)
Figure 2.2: The Jaccard coefficient between k-neighborhoods provides a similarity measure
that reflects the structure of data density. (a) Two densities separated by a sparse region.
The red, green, and blue points are mutually equidistant (in the Euclidean sense). (b) The
open shapes label the k-neighborhoods of the three equidistant points by corresponding color
(k = 25). The magnitude of the Jaccard coefficient between each pair of neighborhoods is
represented by the width of the line connecting each colored point. Note that the lines would
have equal width if similarity were quantified by the Euclidean metric alone. (c) A second
point within the bottom-right density illustrates the relative insignificance for the blue point
of the small neighborhood overlaps it shares with the red and green points.
Figure 2.3: The same sample data as in
Figure 2.2. The Jaccard weight is calcu-
lated between all k-neighborhoods (k =
25) and the vertex degree at each point
i (
∑
j Wij) is represented by color. Points
that are central to dense regions have the
largest degree.
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graph uses consensus between the perspectives of each point to penalize spurious edges and
to strengthen well-supported ones.
2.2.2 Community detection in a graph of phenotypes
Once a graph, G, has been constructed, identifying subpopulations can be cast as a search for
highly interconnected subgraphs of G. To this end we borrow from social network research,
which has developed powerful algorithms to partition large networks into communities [80].
In our setting, communities represent an accumulation of phenotypically similar cells that
likely reflects biologically meaningful phenotypic stability, thus revealing stable cellular states
in the population. Partitioning the graph into these communities produces a dissection of the
population into phenotypically coherent subpopulations.
A simple yet powerful measure on the community structure of a graph is the modular-
ity. For a (weighted) graph and a set of community assignments C = {C1, C2, . . . , CK}, the
modularity is:










where Wij is the edge weight between vertices i and j, ci ∈ {1, . . . ,K} is the community
assignment of vertex i, the Kronecker delta function δ(u, v) = 1 if u = v and 0 otherwise,
and m =
∑
ij Wij is the total weight in the graph and serves as a normalization factor [81].
The modularity quantifies the total intra-community edge weight beyond what is expected by
chance from the number of edges and the degree distribution. The modularity is 0 when the
partition C is random, and reaches a maximum of 1 when edges exclusively connect vertices
in the same community, i.e., when C identifies K disconnected components.
Given some proposed community assignments C, Eq. 2.3 can be used as a quality measure
on the partition. Alternatively, Eq. 2.3 can be used as an objective function that is maximized
in the search for a good partition. In this respect, it is interesting to note that Eq. 2.3 is
somewhat similar to Eq. 1.1, the k-means objective function. Given an assignment of points
to discrete classes, both provide a quality measure based on the “tightness” of the points in
each class. Modularity has other desirable properties, not least of which is taking into account
CHAPTER 2. EXTRACTING CELL STATES FROM GRAPHS 41
an expected value of tightness for random partitions.
Note that while much of the theory and algorithmic development regarding modular-
ity have been pursued and applied in social network analysis, it is actually a more general
quantity. Equation 2.3 is formally equivalent to the Hamiltonian of the Potts model of statis-
tical mechanics; as such, it is a natural quantity describing the “correctness” (in an energy-
minimization sense) of an assignment of interacting elements to a number of discrete states
[82].
Finding a set of community assignments that maximize Eq. 2.3 is a combinatorial op-
timization problem for which exact solutions are computationally intractable but for which
good heuristic approximations have been developed. In particular, the Louvain method [83]
has become popular due to its efficiency on large graphs (up to hundreds of millions of ver-
tices). The Louvain method is hierarchical and agglomerative. At the beginning of the first
iteration every vertex is placed in its own cluster. At each iteration, all vertices are scanned
and each vertex vi is added to the community of its neighbor vj that yields the greatest
increase in modularity, ∆Q. If there is no vj such that ∆Q > 0, vi is left in its current
community. The process is repeated hierarchically (representing bottom-level communities as
vertices in the next iteration, etc.) until no further increase in Q is obtained. An appealing
property of the Louvain method is that eventually moving to a new hierarchical level does
not increase Q, suggesting that a “natural” resolution has been reached. Because the same
objective function is used throughout, the top level of the hierarchy is guaranteed to have a
higher modularity score than a level below and the communities specified at the top level can
be taken as the clustering solution. Thus, the number of clusters is determined in parallel
with the communities themselves and reflect a level of detail that is optimal with respect to
the modularity.
PhenoGraph
Combining the concepts discussed above, we developed PhenoGraph, an algorithmic approach
to defining subpopulations in single-cell data. PhenoGraph begins by converting single-cell
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measurements to a graph of phenotypes. The Jaccard graph is used, which incorporates crucial
information about the data density by way of edge weights. These weights are instrumental in
defining strongly interconnected communities of phenotypes according to the modularity score
(Eq. 2.3). The Louvain method is used to find a partition of the graph into communities
that maximize the modularity. Because the output of the Louvain method depends on a
random initialization, PhenoGraph runs multiple random restarts in order to avoid poor
local maxima and ensure a high-quality solution. Pseudocode for PhenoGraph is presented
in Algorithm 1. Two open-source software implementations of PhenoGraph are currently
available: a standalone Python version3 and as part of the Matlab single-cell analysis toolbox
cyt developed in our lab.4
Algorithm 1 PhenoGraph Clustering
In: Single-cell measurements X = [x1, . . . ,xN ], neighborhood size k, r random restarts
Out: Subpopulation assignments C
procedure Graph Construction(X, k)
for all i ∈ {1, . . . , N} do









while t < r do
Ct ← Louvain(W)
Qt ← Q(W, Ct)
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While the number of random restarts of the Louvain subroutine can be considered an
input parameter to PhenoGraph, in practice we found that each restart tends to produce
results highly similar to the others, such that good results are found within a small number
of solutions. For example, the standard deviation of modularity scores obtained from 100
random restarts on test data (§2.3) was extremely small (8.75 × 10−4). Once the graph has
been constructed the computational cost of random restarts is small and this parameter can
be fixed at some moderately large value (e.g., 50), or other heuristics can be used to determine
that a solution is not a poor local maximum.
2.3 Validation with normal bone marrow data
Healthy human bone marrow, which is rich in distinct and well-characterized immunological
cell types, presents an opportunity to evaluate the performance of computational methods for
subpopulation discovery. In particular, two questions are of interest:
1. Do clustering solutions recapitulate ab initio the immunological subsets that are known
from decades of research?
2. Does PhenoGraph perform favorable in comparison to other methods?
To address these questions, three validation data sets were assembled, comprising mass cytom-
etry measurements of bone marrow mononuclear cells (BMMCs) from three healthy donors.
Validation Data Set 1 (VDS1) was a publicly available mass cytometry data set [17]
(http://reports.cytobank.org/1/v1) of healthy adult BMMCs. It consisted of 167,044
cells collected from a healthy human donor (“Marrow 1” in [17]), which had been manually
assigned to 24 cell types by standard immunological gating techniques in the original pub-
lication. The gating strategy for manual assignment was based on the 13 surface markers
measured in this data: CD45, CD45RA, CD19, CD11b, CD4, CD8, CD34, CD20, CD33,
CD123, CD38, CD90, CD3. These 13 markers were also used for all computational analyses.
Manual gating assigned 49% of the cells to a known cell type while the remaining cells were
not assigned to any known cell type.
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Figure 2.4: 30,000 random cells from VDS1 with manual cell type assignments, visualized
with t-SNE. Cells are colored by cell type assignments established by manual gating (left
panel) or subpopulations detected by PhenoGraph (right panel).
Validation Data Sets 2 & 3 were newly collected mass cytometry measurements of 32
surface markers on BMMCs from two healthy adult donors. Measurements from these samples
were manually gated into 14 cell types based on 19 markers measured in this data: CD3,
CD4, CD7, CD8, CD15, CD16, CD19, CD20, CD34, CD38, CD41, CD44, CD45, CD61,
CD64, CD123, CD11c, CD235a/b, HLA-DR (note that manual gating becomes extraordinarily
difficult even at this dimensionality). The full 32 marker-panel was used for all computational
analyses of these data. (Data are available for download at http://cytobank.org/nolanlab/
reports).
Before a systematic evaluation, it is instructive to visualize the performance of Pheno-
Graph and other methods on healthy bone marrow. For this purpose, we assembled a curated
sample of 30,000 cells from VDS1 that included only cells that were assigned to a known cell
type by the manual gating strategy. PhenoGraph was run on this sample to obtain a data-
driven approximation to the manually-defined cell types. Figure 2.4 shows the PhenoGraph
assignments in direct comparison to the manual assignments, visualized by t-SNE. Note that
neither t-SNE nor PhenoGraph use the manual assignments in any way. Also note that both
t-SNE and PhenoGraph are run directly on the data matrix and that PhenoGraph does not
use any information from t-SNE.
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A qualitative analysis of Figure 2.4 reveals that PhenoGraph correctly identifies clusters
corresponding to most major healthy cell types including naive and mature CD4+ T cells,
naive and mature CD8+ T cells, natural killer (NK) cells, CD11b+ and CD11b− monocytes,
pre-B cells, plasmacytoid dendritic cells (pDCs), megakaryocytes and erythroblasts. It found
a single cluster of early B cells, grouping together the manually assigned Pre-B I and Pre-B
II populations. It found two mature B-cell clusters, splitting the B-cell population into two—
based on low and mid expression of CD123—in a manner that appears corroborated by the
structure of the t-SNE map.
2.3.1 Quality measures
To quantify the agreement of clustering solutions with the manual assignments, we used two
alternative quality measures: the mean F -measure and the normalized mutual information
(NMI). The mean F -measure was used in the recent FlowCAP competition and we used this
procedure as described in their publication for the sake of consistency [71].
For each “ground truth” subpopulation γi in the benchmark data and a cluster cj returned
by the algorithm, Precision (Prij) quantifies the proportion of cj that identifies γi, Recall
(Reij) quantifies the proportion of γi that is identified by cj , and the F -measure is defined as
the harmonic mean of these quantities:
F (γi, cj) =
2 · Prij · Reij
Prij + Reij
(2.4)
The F -measure quantifies the accuracy of a binary classification, but can be extended to








F (γi, cj) (2.5)
where |γi|/N is the proportion of the validation data in subpopulation γi and C = {c1, . . . , cK}
is the clustering solution being evaluated. The mean F -measure is bounded by the interval
[0, 1] with 1 representing a clustering solution that perfectly matches the ground truth (in
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this case, the manually-defined subpopulations).
To avoid any possible biases inherent in the mean F -measure, we also used the normalized
mutual information (NMI), another popular clustering quality measure. This score treats the
true cluster assignments and the output of the algorithm each as discrete random variables
and quantifies their statistical redundancy, which reflects the clustering accuracy (note that a
perfect clustering result and the true labels are completely redundant—they contain exactly






P (γ, c) log




which is non-negative but otherwise unbounded. The normalized variant
NMI(Γ, C) = I(Γ; C)√
H(Γ)H(C)
(2.7)
where H(·) is the Shannon entropy, reaches a maximum of 1 when C ≡ Γ.
2.3.2 PhenoGraph outperforms leading methods
Besides the quality of the clustering solution itself, there are other desirable properties to be
evaluated. These are:
Robustness. The method should produce similar results under small perturbations of the
data such as random resampling
Automation. The method should not require too many user-defined parameters and should
produce similar results under small perturbations of their values
Scalability. The method should be able to process large, high-dimensional samples in a
reasonable amount of time
Note that automation can be viewed as another form of robustness, i.e. robustness to user
input.
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I evaluated PhenoGraph on all these criteria together with the three best-performing
open-source methods tested by the FlowCAP consortium: FLOCK [76], flowMeans [75],
and SamSPECTRAL [77]. Additionally, two commonly used “general purpose” clustering
methods were included: the Gaussian mixture model and hierarchical linkage. PhenoGraph
quantifiably outperformed all competing methods, as detailed below.
For all comparisons the following implementations were used: FLOCK 2.0 (FlowCAP-I
version) implemented in C; flowMeans 1.18.0 (Bioconductor version 3.0) implemented in R;
SamSPECTRAL 1.20.0 (Bioconductor version 3.0) implemented in R. While FLOCK and
flowMeans have no user-defined input, SamSPECTRAL requires tuning of two parameters,
sigma (σ) and separation factor (sf ), which were tuned as recommended in the user guide for
that software. For hierarchical linkage clustering and Gaussian mixture models, the Matlab
R2013b implementations were used. In principle, those methods are not comparable because
they require specification by the user of the number of subpopulations. In our testing, we
provided this number to these methods (which is of course known for the validation data),
though this did not result in an impressive performance from either method.
Integrated quality and robustness analysis
Cluster solution quality and robustness were evaluated simultaneously in the following man-
ner. From each validation data set, we generated 50 random subsamples of 20,000 cells each.
Each method was run on each subsample and the mean F -measure and NMI were computed
on each individual output. This procedure generated distributions of quality measures for
each method. Ideally, these distributions should have a high center (indicating high aver-
age solution quality) and small variance (indicating robustness to random resampling). The
distributions of mean F -measure for the VDS1 subsamples are shown in Figure 2.5.
I also used the random subsamples to evaluate PhenoGraph’s robustness to the user-
defined parameter k. Clustering solutions were generated by PhenoGraph for each subsample
at four values of k spanning a four-fold range. As shown in Figure 2.5, the value of k has
essentially no impact on the quality of the solution or the sensitivity to random resampling.
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Figure 2.5: Distributions of mean F -measure obtained for each method on 50 random sub-
samples from VDS1.
This type of analysis could not be performed for FLOCK or flowMeans because those
methods are completely automated—they take no input parameters. SamSPECTRAL takes
two input parameters that require careful tuning. Instead of testing the quadratic number of
possible pairs for the two parameters, these were selected as recommended in the user guide
for that software.
All results using NMI were virtually identical and are omitted for space, but can be found
in the supplementary material of [84].
From this analysis, it can be concluded that PhenoGraph outperforms all competing meth-
ods in terms of solution quality and robustness.
Analysis of scalability
As before, the input data matrix is N × D. It is desirable that a method scale well with
increases in both N and D.
PhenoGraph exhibits superior scaling with dimensionality D
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The FlowCAP consortium tested performance on flow cytometry data only; methods
that performed well there were probably not designed for the higher dimensionality of mass
cytometry data. The 32-dimensional data of Validation Data Sets 2 & 3 makes this clear. As in
the previous analysis, we generated 50 subsamples from VDS2 and VDS3 to generate quality
measure distributions for each method. The results are presented in Figure 2.6. FLOCK
was unable to run on these data sets because it assumes that the number of observations
is vastly greater than the number of dimensions to the the extent that a 20,000-cell test
set contained “’too few” observations for 32-parameter data. SamSPECTRAL was able to
run, but with poor results and poor computational efficiency; flowMeans produced better
results than SamSPECTRAL but at an enormous cost in terms of run time. Furthermore,
the performance of flowMeans was highly unstable, sometimes producing good results and
sometimes failing completely due to numerical underflow. Out of 100 runs, flowMeans failed
to produce any result on 59 occasions. On the other hand, PhenoGraph continued to exhibit
high quality, robust results and fast run times.
PhenoGraph exhibits superior scaling with number of observations N
Finally, we tested the scaling behavior as the data matrix contains increasing numbers
of observations. Testing was conducted on 32-parameter data sampled from VDS2. At each
sample size, N ∈ {20, 40, 60, 80, 100} × 103, 5 random samples were generated. The small
number of samples was motivated by the mounting inefficiency of flowMeans and SamSPEC-
TRAL, which scale exponentially with N (Figure 2.7). PhenoGraph displays roughly linear
scaling with N .
All performance comparisons were conducted on a 2.6 GHz Intel Core i7 with 16GB of
RAM. At 80,000 cells, average run time was 105 minutes for SamSPECTRAL, 254 minutes
for flowMeans, and 5 minutes for PhenoGraph. In the time it takes flowMeans to process
80,000 cells, PhenoGraph can process 106 cells.
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Figure 2.6: NMI, mean F -measure, and run time distributions for 50 random subsamples of
20,000 cells each from VDS 2 & 3.
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Figure 2.7: Systematic comparison of run time as a function of sample size. PhenoGraph (run
here with k = 30) displays significantly superior computational efficiency and scales roughly
linearly with the number of cells. Lines trace mean run time for 5 random samples at each
sample size and error bars display the standard error.
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2.4 Summary
In this chapter, we considered the fundamental problem of identifying cellular subpopulations
in single-cell data. The particular features of single-cell data should be considered in designing
an algorithmic solution to the problem. We used the conept of the phenotypic manifold
(§1.3.4) to motivate our graph-based method, PhenoGraph. PhenoGraph uses a graph of
single-cell phenotypes to approximate the phenotypic manifold and translates the task of
density detection to the problem of modularity optimization in this graph.
Healthy human bone marrow contains a diversity of cell types well known through decades
of research. Thus, single-cell measurements of bone marrow cells provide a good benchmark
data set, where manual gate assignments provide an approximate gold standard. Using several
such benchmark data sets, we showed that PhenoGraph is superior to other comparable
methods in terms of all relevant metrics: PhenoGraph is computationally efficient and able to
run on very large data sets without subsampling; PhenoGraph produces high quality results
that closely resemble manual cell type assignments obtained through decades of experimental
studies; PhenoGraph is robust, producing highly similar irrespective of the exact subsample
of data points used and the exact setting of its single user-defined parameter.
The ability to reconstruct ab initio the known cell types of a well-characterized tissue is
an important demonstration of the method’s reliability. Ultimately, the data-driven approach
becomes truly powerful when applied to less characterized systems, where we do not presume
to know the subpopulation structure in advance. The quality of PhenoGraph’s performance
in the benchmark data translates to confidence in the biological significance of subpopula-
tions it identifies in samples of unknown structure. In Chapter 4, PhenoGraph is used to
identify subpopulations in leukemic marrow, where the subpopulation structure remains an
open question.
Chapter 3
Classifying cells with random walks
Central to PhenoGraph is its underlying graph structure, constructed by representing data
points as vertices connected by edges that capture their phenotypic and structural similari-
ties. By partitioning this graph into maximum-modularity communities, we obtain a success-
ful phenotypic dissection of the sample into subpopulations representing robust cell states.
Theoretically, the reason for PhenoGraph’s success is that the graph G is a good approxi-
mation to the phenotypic manifold P. If so, then G should be useful for other tasks related
to learning about P. In this chapter, we consider the case where there is partial knowledge
about the data and we want to extend this knowledge to uncharacterized cells. For example,
we might construct a data set by concatenating measurements of known cell types together
with a sample from some disease state. We could then ask, for each cell in the disease sample,
what healthy cell type is it most similar to?
Another interesting application is recovering cells that are missed by manual gating strate-
gies. Unlike data-driven approaches, manual gating labels only a portion of cells in a sample—
those falling squarely within boundaries manually drawn in sequential bivariate subspaces of
the data. As mentioned in Section 2.3, despite the fact that the authors of [17] were able
to define 24 cell types from 13 dimensions by manual gating, 51% of cells “fell through the
cracks” and were not assigned to any cell type. In this case, manual assignments can be
considered as partial labels providing “seed” information about cell types. Computationally
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extending the manual assignments to the unlabeled cells may not only prevent the loss of so
much data, but may also reveal unappreciated phenotypic features of these cell types when
they are identified in this more data-driven manner.
3.1 Problem formulation
Formally, consider a data set X = [x1, . . . ,xN ] in which L < N points are assigned to one of
M distinct classes. Without loss of generality, the assigned points are the first L rows of X
and their assignments are given by the vector y = [y1, . . . , yL], which assigns each of the first
L samples in X to one of M distinct classes. The inference task is to compute assignments
for the unlabeled points, y′ = [yL+1, . . . , yN ]. Because the task is to assign unlabeled points
to classes specified in y, this is a classification problem. As such, the labeled points are called
the training data and the unlabeled points are called the test data.
In machine learning, this style of classification is called semi-supervised or transductive
learning. It differs from supervised or inductive learning in that both the training and test
data are given up front. Thus the inference procedure is permitted to use not only the features
of the training data but also the structure of the entire data set to generate classifications.
This is a powerful advantage indeed, largely for the same reasons that motivate the use of a
graph for manifold learning. When assessing whether an unlabeled point is similar to a set of
labeled points, their respective locations on a low-dimensional manifold should be at least if
not more informative than metric distances in high-dimensional space.
3.2 PhenoGraph Transductive Learning
The extension of PhenoGraph to the transductive case can be thought of as a refinement
of the k-nearest neighbors classifier, a classical and very simple non-parametric supervised
learning technique. In that method, for each unlabeled point xi, the k nearest labeled points
are identified and xi is classified as the majority class among those k labeled points. This
approach is vulnerable to many pitfalls. For example, small changes in k can easily tip the
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balance of the majority from one class to another, except in the simplest cases. Because it
is inductive rather than transductive, this method treats each unlabeled point independently,
rather than transferring information between the unlabeled points as classifications accrue.
Reformulating the problem as a transductive learning task allows relaxation of the strict value
k to a more “distributed” vote that takes into account the larger-scale structure of the data.
Intuitively, each point i is allowed to be influenced by labeled vertices beyond its immediate
neighborhood, connected to i through multiple edges in the graph. The classification becomes
a weighted vote, averaged over the entire graph. The weights are derived from a probabilistic
interpretation of the graph connectivity using random walks. A random walk is a path through
the graph where, at each vertex i, the next vertex is selected probabilistically from the set of
i’s neighbors, V(vi). The proximity of two vertices can be computed as the probability of a
random walk passing through both—which, because it averages over all possible walks—is a
powerful and robust measure of vertex similarity that takes into account the entire structure
of the graph. Discussed below, this framework provides the mathematical foundation to
allow a set of partial vertex labels to “diffuse” through the graph onto the unlabeled vertices,
producing transductive classifications.
To extend PhenoGraph to the transductive case, we begin with the same graph con-
struction procedure as before, using the Jaccard coefficient between k-neighborhoods as edge
weights. The graph is constructed using all data and without reference to the labels. At this
point, the graph is dappled with labeled vertices which act as landmarks for regions of the
graph associated with the various classes (Figure 3.1).
Exploiting the connection between random walks on graphs and discrete potential theory
[85], the probability of cell i being assigned each class m can be calculated by solving a system
of linear equations representing the electric potential at each unlabeled node when voltage is
alternatively applied to the vertices of each labeled class [86]. Each unlabeled node is then
assigned to the class that it reaches first with highest probability.
Given a partially labeled data set (X,y), compute the Jaccard graph as described in Sec-
tion 2.2.1. From the weight matrix W and its degree matrix D = diag(deg(v1), . . . ,deg(vN )),
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Figure 3.1: Schematic depiction of PhenoGraph Tranductive Learning. The graph is built
without consideration of the class labels (bold colors) and each unlabeled vertex is classified
(light colors) according to the class that is most likely reached first by a random walk in the
graph.
the graph Laplacian is defined:
L = D −W (3.1)
Note that each vertex is either labeled or unlabeled and therefore must be in one of two sets,
VL (labeled vertices) and VU (unlabeled verticies), VL ∪ VU = V and VL ∩ VU = ∅. Thus L





The graph Laplacian is used to compute the probability that random walks originating at
verticies in VU first arrive at particular classes in VL. These probabilities can be calculated
through the solution of a system of sparse linear equations (see [86] for complete derivation).
Specifically,
LUP = −BTQ (3.3)
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where Q is a L ×M binary matrix representing the class of each vertex in VL and P is a
(N − L) ×M matrix containing the desired probabilities for every vertex in VU . In other
words, each row j of P is a M -dimensional probability vector (
∑M
m=1 Pjm = 1) expressing the
probability that a random walk departing from vertex j arrives first at a vertex in class m.
Therefore, the matrix P is the quantity of interest, as it provides a probabilistic assignment
of each point to each class (similar to the “responsibilities” of parametric mixture models).
Every unlabeled data point can be assigned to the most probable class
yj = arg max
m
Pjm (3.4)
or the assignments can be chosen more elaborately. For example, the entropy H(Pj) provides
a direct measure of the uncertainty of assigning j to any class; this can be used to rank and
filter assignments to control the quality of the inference.
Psuedocode summarizing PhenoGraph Transductive Learning (PTL) is given in Algorithm
2.
Algorithm 2 PhenoGraph Transductive Learning (PTL)
In: Single-cell measurements X = [x1, . . . ,xN ], partial labeling y = [y1, . . . , yL], neighbor-
hood size k
Out: Completed labeling y′ = [yL+1, . . . , yN ], matrix of assignment probabilities P
procedure Graph Construction(X, k)
for all i ∈ {1, . . . , N} do






Compute Eq. 3.1 and Eq. 3.2
Solve Eq. 3.3 for P
return P
end procedure
Option: y′ 3 yj ← arg maxm Pjm
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Figure 3.2: Entropy distribution of random walk probabilities for unlabeled cells. High val-
ues indicate classification uncertainty. The vertical dashed line indicates the filter used to
eliminate cells with high classification uncertainty.
3.3 Using random walks to recover cells missed by manual
gating
To demonstrate the capabilities of PTL, we revisit Validation Data Set 1 (§2.3), comprising
> 100, 000 healthy bone marrow cells with 13 surface marker dimensions and partial labels
obtained by manual gating, which cover 49% of cells. PTL was run with k = 30 to obtain
P and the entropy H(Pj) was used to filter the classifications (Figure 3.2). This resulted
in the recovery of 83% of the unlabeled data, increasing the total number of labeled cells
by 86%. The number of recovered cells per cell type is shown in Table 3.1. For many cell
types, the recovered cells outnumber the manually gated cells, reflecting not only the power of
this approach but also the power of defining cell types in multiple dimensions simultaneously
rather than sequentially.
For example, the number of common myeloid progenitors (CMPs) was doubled by algo-
rithm. The marker distributions for the inferred CMPs are very similar to the manually-
defined cells (Figure 3.3). The most notable difference is modestly elevated expression of
CD4, though still at levels less than what would be considered “CD4+” for a T cell. Since
robust CD4 expression is a lineage marker for T helper cells, most gating strategies for pro-
genitors include a “CD4−” gate early in the sequence and these cells are lost as a result. The
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Manual Gating Recovered
CD11b− Monocyte 912 2134
CD11bhigh Monocyte 6779 19036





Immature B 502 68
MEP 194 438
MPP 152 17
Mature CD38low B 7796 3930
Mature CD38mid B 608 482
Mature CD4+ T 13964 6083




Naive CD4+ T 6987 7054
Naive CD8+ T 9564 5010
Plasma cell 468 575
Plasmacytoid DC 293 478
Platelet 5 0
Pre-B I 240 105
Pre-B II 994 558
Table 3.1: Number of cells recovered from manual gating by PhenoGraph transduction, listed
by cell type.
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Figure 3.3: Gated (blue) and inferred (green) CMPs show similar marker distributions.
distribution of the other 12 markers, however, corroborates that these cells are CMPs.
Another interesting example are the NK cells, where the inferred number of cells more
than doubles what was gated manually. Again, the marker distributions are very similar
between the gated and the inferred NK cells with one notable exception: about half of the
inferred NK cells express CD8 at a moderate intensity (i.e., less than CD8+ T cells; Figure
3.4). In fact, it has been previously reported that about half of human NK cells do express
CD8 at this moderate intensity [87]. While the manual gating strategy in [17, Fig. S5] defined
NK cells as CD8−, transductive learning by PhenoGraph recovered both CD8+ and CD8−
NK cells. Given that some of the inferred NK cells express moderate levels of CD3, it is worth
noting that the CD8+ inferred NK cells are indeed CD3− and are therefore not a side effect
of misclassified cytotoxic T cells (Figure 3.5). The small number of CD3mid cells included
among the inferred NK cells are CD4−/CD8− and many express CD90 (data not shown); it
is difficult to establish their identity with the limited markers available in this particular data
set.
3.4 Summary
In this chapter, I introduced an extension of PhenoGraph that uses the same underlying
graph structure to perform a different kind of inference task—namely, transductive learning.
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Figure 3.4: Gated (blue) and inferred (green) NK cells show similar marker distributions with
the notable exception of CD8.
Figure 3.5: Scatter plot showing all inferred NK cells. The CD8+ inferred NK cells are CD3−.
The dashed gray vertical and horizontal lines show average CD3 expression among all gated
T cells and average CD8 expression among gated CD8+ T cells, respectively. Color represents
the local density at each point.
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A simple performance evaluation using manually gated normal bone marrow suggests that
the method successfully finds correct classifications for unlabeled data when labeled examples




of acute myeloid leukemia
A critical area of application for the data-driven methods discussed so far is human disease
and especially cancer biology. Though tumors have sometimes been conceptualized as simple
agglomerations of malignant cells, a parallel body of research treats cancer as a diseased tissue
[88]. If tumor cells or more broadly the tumor microenvironment—comprising neoplastic cells,
tumor infiltrating leukocytes, activated stromal cells—form a complex population with func-
tional differentiation, then the structure of this population may be critical for understanding
and controlling the disease.
In fact, research increasingly supports the proposition that intratumor heterogeneity is
functionally and clinically significant [89]. Recent evidence implies that the pathobiology of
cancer results from the actions and interactions of diverse subpopulations within the tumor.
Because tumors defy the regulatory mechanisms that bring healthy tissues into such unifor-
mity across individuals, it is difficult to know prospectively what the subpopulation structure
of a tumor might be like. To uncover the unknown subpopulation structure of malignancies,
it is therefore critical to obtain measurements that preserve single-cell resolution and capture
as many simultaneous dimensions as possible. The high dimensionality can be exploited by
data-driven techniques which, as shown in the previous chapters, can identify ab initio the
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diversity of cellular states in the population.
4.1 Acute myeloid leukemia
Intratumor heterogeneity is pervasive in acute myeloid leukemia (AML), an aggressive liquid
tumor of the bone marrow characterized by overwhelming abundance of poorly differentiated
myeloid cells (“blasts”). Arising from the disruption of regulated myeloid differentiation [90],
AML results in a disordered developmental hierarchy wherein leukemic stem cells (LSCs) are
capable of re-establishing the disease in immunodeficient mice [37]. LSCs were first thought
to display the same CD34+/CD38− cellular phenotype as normal hematopoietic stem cells
(HSCs). Subsequent studies demonstrated a disconnect between the surface phenotype and
the functional state of LSCs, with both CD38+ [38] and CD34− [39] LSCs having been re-
ported. While almost all cases of AML do exhibit a differentiated hierarchy (i.e., LSCs are
typically only a subset of blasts), no surface marker phenotype has been identified that con-
sistently indicates LSCs across patients [43].
Recognizing this disconnect between functionally primitive cells (e.g., tumor-initiating,
“stem-like”) and their surface phenotypes, we designed experiments to simultaneously assay
surface protein expression and regulatory signaling in millions of individual cells from pri-
mary AML samples. While the functional state of the cell is not directly measurable (§1.3.1),
we reasoned that it may be more reliably inferred from intracellular signaling as opposed to
membrane-bound protein expression. The simultaneous measurement of surface and intracel-
lular features was enabled by the expanded dimensionality of mass cytometry (§4.2). Cells
were measured both before and after several ex vivo molecular perturbations, which elicit
intracellular responses that reflect the broader signaling network beyond what can be inferred
from the unperturbed state [46]. Computational integration of these signaling responses fur-
ther expanded the dimensionality of the data (§5.1.1).
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4.2 High-dimensional single-cell profiling of an AML cohort
We used mass cytometry to obtain single-cell proteomic profiles of cryopreserved bone marrow
aspirates from pediatric AML patients obtained at diagnosis (n = 16) and from healthy
adult donors (n = 5). We performed preliminary analysis to select 16 highly informative
surface markers that efficiently captured the intra- and intertumor heterogeneity in our cohort
(§A.2.2). We added 14 antibody probes against intracellular phosphorylation, thus allowing
simultaneous measurement of surface phenotype and signaling behavior in single cells. Each
sample was subjected ex vivo to a battery of short-term molecular perturbations (cytokines
and chemical inhibitors; see Appendix for details) to elicit functionally relevant signaling
responses [17, 46]. The complete data set contained over 15 million single cells from 21
individuals measured in 31 simultaneous protein dimensions following exposure to one of 17
conditions (Table 4.1). A summary of the experimental design and first-stage analysis is
provided in Figure 4.1.
4.3 PhenoGraph reveals a “landscape” of leukemic states
While healthy bone marrow is known to contain well-separated subpopulations (§2.3), it was
questionable to what extent this would be true in the AML samples. We explored this question
in previous work [68], where we found evidence that leukemias contain heterogeneous states
that are more overlapping than what is observed in healthy marrow. These observations were
corroborated by the additional 5 healthy and 16 leukemic samples investigated in the present
study.
All healthy samples presented highly distinct and reproducible cell types, identifiable
through their known marker combinations. Each leukemia also presented a diversity of phe-
notypes defined by distinct combinations of surface marker expression. For example, Figure
4.2 shows bone marrow cells from a single representative leukemia patient (SJ03) mapped into
two dimensions by t-SNE. The resulting phenotypic landscape is diffuse compared to normal
bone marrow, yet it is characterized by regions of distinct expression patterns.
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Figure 4.1: Profiling normal and malignant surface and signaling phenotypes by mass cytom-
etry. (A) Mass cytometry profiling of an AML cohort with healthy controls. (B) PhenoGraph
was used to identify the subpopulations in each sample individually. This panel shows the
graph built from 500 randomly selected cells of healthy donor H1. Each vertex is colored
by CD34 expression of its corresponding cell (right). CD34+ hematopoietic stem and pro-
genitor cells (HSPCs) form a densely interconnected subgraph and are assigned to a single
subpopulation by community detection (middle). (C) Each subpopulation is a multifaceted
data object containing surface marker distributions as well as perturbed intracellular signal-
ing. Shown here, the HSPCs identified by PhenoGraph in donor H1 (red histograms) had a
CD34+/CD45low phenotype relative to the other cells in the sample (gray histograms). Each
PhenoGraph subpopulation contained cells from all perturbations, permitting analysis of 224
signaling responses as shown in the heat map on the right.
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Surface Markers Signaling Markers Molecular Perturbations
CD19 PLCγ2 (pY759) Basal (i.e. PBS only)
CD11b 4EBP1 (pT37/46) AICAR
CD34 AMPK (pT172) BEZ-235
CD123 STAT3 (pY705) Flt3L (Flt-3 ligand)
CD45 S6 (pS235/pS236) G-CSF (granulocyte CSF)
CD33 CREB (pS133) GM-CSF (granulocyte-monocyte CSF)
CD47 STAT5 (pY694) IFNα (interferon α A/D)
CD7 c-CBL (pY700) IFNγ (interferon γ)
CD15 STAT1 (pY701) IL-10 (interleukin-10)
CD44 ZAP70/SYK (pY319/pY352) IL-27 (interleukin-27)
CD38 AKT (pS473) IL-3 (interleukin-3)
CD3 RB (pS807/pS811) IL-6 (interleukin-6)
CD117 ERK1/2 (p44/42) (pT202/pY204 ) PMA/Ionomycin
HLA-DR P38 (pT180/ pY182) PVO4 (pervanadate)
CD41 SCF (stem cell factor)
CD64 TNFα (tumor necrosis factor α)
TPO (thrombopoietin)
Table 4.1: Markers and perturbations used for single-cell profiling. All signaling mark-
ers target phosphorylated epitopes at the amino acid residues specified in parenthe-
ses. CSF: colony stimulating factor; AICAR (5-Aminoimidazole-4-carboxamide 1-beta-D-
ribofuranoside): pharmaceutical AMP-dependent protein kinase inhibitor; BEZ-235: phar-
maceutical phosphoinositide 3-kinase inhibitor; PMA (phorbol 12-myristate 13-acetate): to-
gether with ionomycin induces cytokine production in many cell types. Further details can
be found in Table A.1 below and in the supporting materials of [84].
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Figure 4.2: t-SNE map of bone marrow cells from patient SJ03. Each point represents a single
cell, colored according to its measured expression of the indicated marker. All 16 available
surface markers were used to generate the map; 3 are chosen as examples.
As mentioned previously (§2.1), reduction to two dimensions is required for visualization
but is not necessarily optimal for identifying subpopulations in the original high-dimensional
space. PhenoGraph, which circumvents the strong requirement of a two-dimensional projec-
tion, identified multiple subpopulations characterized by substantial phenotypic differences in
the leukemia samples. Figure 4.3 shows clusters identified by PhenoGraph in sample SJ03
as colored labels on the t-SNE map of Figure 4.2. It is interesting to note that the Pheno-
Graph clusters accentuate subtle structures in the map that may not be obvious at first
glance. A PhenoGraph cluster may comprise phenotypic “pockets” from disconnected regions
of the map—such as Cluster 12 in Figure 4.3—that may reflect suboptimal splits as t-SNE
searches for the highly compressed two-dimensional projection. In the case of Cluster 12,
these two pockets are kept together by PhenoGraph because they are characterized by CD117
expression, as can be observed in Figure 4.2. An overview of subpopulations identified by
PhenoGraph in patient SJ03 is given in heat map form in Figure 4.4. In addition to some
non-myeloid cell types, there are clearly different leukemic phenotypes in this patient, defined
particularly by distinct combinations of CD34, CD117, HLA-DR, and CD64.
To analyze the full cohort, PhenoGraph was run on each sample individually, using each
cell’s 16-dimensional surface marker profile to define phenotypes. This yielded an average
of 28 subpopulations per sample (ranging between 17 and 48), totaling 616 subpopulations
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Figure 4.3: Clusters found by PhenoGraph in patient SJ03, displayed as colored labels on the
t-SNE map shown in Figure 4.2. The clusters split the map into coherent structures that are
not always immediately obvious upon inspection of the two-dimensional map.
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Figure 4.4: Clusters found by PhenoGraph in patient SJ03, displayed as a heat map. In this
visual, clusters are separated by gray vertical lines and they are ordered from left to right by
decreasing cell count. Expression values are sorted within each row and within each cluster to
facilitate visualization of the intra-cluster marker distributions. Expression intensities have
been rescaled as a ratio of the maximum “normal” expression intensity, determined from the
5 healthy samples.
across the entire cohort. Subpopulation size varied by orders of magnitude, from 7 × 102
to 2 × 105 cells (or .06% to 20% of a sample). For each sample, data were pooled from all
perturbations before clustering, enabling characterization of subpopulation-specific signaling
patterns (§5.1.1). Each resulting subpopulation was a multifaceted data object, containing
information about surface phenotypes, as well as the response of each signaling marker to
each molecular perturbation (Figure 4.1).
4.3.1 Patterns of intra- and intertumor heterogeneity
Each leukemia presented a diversity of surface phenotypes that seemed to share some sim-
ilarities and differences across patients. We therefore sought an integrative overview that
could enable direct comparison of all subpopulations simultaneously and reveal larger trends
in the cohort. Toward this end, we used t-SNE, which has been so successful in revealing
the “phenotypic landscape” of single cells. The difference here, of course, is that the objects
being mapped are not single cells but clusters of cells. To generate a map for the entire
cohort, we obtained subpopulation phenotypes by taking the 16-dimensional centroid of the
surface markers of each subpopulation. The landscape generated from the subpopulation
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phenotypes provided an intuitive and comprehensive overview of the major phenotypic trends
of the cohort and also revealed the extent of intra- and inter-tumoral heterogeneity (Figure
4.5). Subpopulations from healthy and leukemic samples were mapped simultaneously so the
healthy cell types could act as “landmarks” to aid interpretation of the leukemic subpopula-
tions. Normal lymphoid cell types were excluded from the landscape to focus on primitive
and myeloid phenotypes, “zooming in” on the myeloid lineages relevant to AML.
The AML cohort landscape organized the subpopulations into regions of phenotypic sim-
ilarity, distinguished by particular marker combinations. Inspecting the structure of this
landscape, we found that the vertical axis largely mimicked trends in normal myeloid devel-
opment with primitive markers expressed toward the top and more mature markers toward
the bottom. Healthy CD34+/CD38mid hematopoietic stem and progenitor cells (HSPCs) pro-
vided the most primitive landmark, located at the top of the landscape. AML subpopulations
in this region displayed surface profiles that resembled the HSPC phenotype. At the bot-
tom of the landscape, the CD11b+ healthy monocytes served as a landmark for differentiated
myeloid cells, representing full maturation not observed in the leukemic samples. Between
these two poles, other developing myeloid antigens—CD38, CD117, CD123, CD33—peaked
and subsided, thus the vertical axis of the landscape resembled normal myeloid development
(Figure 4.6). The adherence of AML phenotypes to this axis suggests that myeloid develop-
mental programs continue to influence the phenotypic diversity of leukemic cells even after
malignant transformation. The patterns of intratumor heterogeneity support this view, as
most patients contained a mixture of “primitive” and “mature” surface phenotypes (Figure
4.7).
4.3.2 Metaclusters highlight inter-patient similarity
Despite the widespread phenotypic diversity observed within patients, the cohort landscape re-
vealed a surprising conformity when comparing AML subpopulations across different patients.
Multiple patients occupied each region of the landscape and no patient presented a substan-
tially unique phenotype, suggesting that subpopulations could be matched across patients,
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Figure 4.5: Landscape of subpopulation phenotypes generated by t-SNE. Each subpopulation
is represented by a single point, scaled to represent its sample proportion and colored by
patient identity (main panel). Normal bone marrow cell types (H1–H5; blue) provide land-
marks for interpreting the phenotypes of the leukemic bone marrow samples (SJ01-SJ16). In
the additional panels each subpopulation is colored by its median expression of the indicated
surface marker.
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Figure 4.6: Gaussian weighted smoothing of subpopulation marker intensity displayed as a
function of the second (i.e., vertical) dimension of the t-SNE map. The axis mimics myeloid
development from left to right, reflected in the fall of CD34 expression, the transient rise of
expression of CD38, CD117 and CD123, and finally the rise of CD64 and CD11b expression.
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Figure 4.7: Subpopulations of each patient visualized separately in the landscape of Figure
4.5. Many patients are split between the top and bottom half of the landscape, which corre-
sponds to primitive and mature-like surface phenotypes (Figure 4.6), suggestive of persisting
developmental processes in most leukemic samples.
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cohort-wide. To examine these cohort-level phenotypes further, we pursued a metaclustering
approach in which subpopulations from each patient were grouped by a secondary clustering
analysis [73]. Defining subpopulation phenotypes as before, we used PhenoGraph to group
the subpopulations into metaclusters (MCs; Figure 4.8 A). Specifically, all 425 AML-derived
subpopulations were analyzed together, leaving out the healthy-derived subpopulations to
avoid bias toward normal phenotypes. PhenoGraph was run with the parameter k = 15,
reflecting the smaller sample size compared to the initial single-cell data.
With 16 patients, the cohort is relatively small and we therefore conducted robustness
analysis to determine whether the MCs were biased by the inclusion of any particular pa-
tient(s). The stability of the metacluster results to perturbations of the cohort was assessed
by subsampling the patients and recomputing the metacluster assignments. Specifically, we
produced 16 leave-one-out and 120 leave-two-out data sets in which all subpopulations from
patient {i | 1 ≥ i ≥ 16} (and {j | 1 ≥ j ≥ 16 ∧ j 6= i} in the case of leave-two-out) were
removed. Metacluster assignments were computed for each subsample as described in the pre-
vious paragraph (k = 15). Each subsample metacluster result was compared to the full-data
MC assignments of the same populations (those retained in the subsample), using normalized
mutual information (NMI; Eq. 2.7) to quantify similarity of the assignments. For reference,
NMI was also computed for 16 random restarts of PhenoGraph using the full cohort data.
While each random restart produced nearly identical results (mean NMI = 0.94), the repro-
ducibility of the metacluster assignments was only modestly diminished by the leave-one-out
and leave-two-out tests, both obtaining average NMI scores of 0.9 with very little variance
(Figure 4.8 B).
The full-data metaclustering solution identified 14 MCs that represent the major cohort-
wide phenotypes. Each MC had a mixed patient composition, containing subpopulations
from at least 2 patients and a median of 11 patients (Figure 4.9A). The average surface
marker patterns of some MCs resembled normal cell types and to varying extents (Figure
4.9B). For example, the CD19+/HLA-DR+ phenotype of MC12 matched the phenotype of
mature B cells, and indeed AML patients are expected to have normal B cells. Other MCs
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Figure 4.8: Metaclustering defines cohort-wide AML phenotypes. (A) PhenoGraph metaclus-
ters split the AML landscape into major phenotypes, each containing subpopulations from
multiple patients. (B) Reproducibility of PhenoGraph metaclusters as assessed by cross-
validation.
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had marker profiles that resembled progenitors in different ways. To more formally evaluate
the relationship between MCs and healthy cell types, cells from the healthy samples (H1–H5)
were systematically matched to MC marker profiles using linear discriminant analysis [91].
In this setting, each MC is given a multivariate normal density in 16-dimensional space with
a shared covariance matrix, using the maximum likelihood estimates from the AML data.
We can formally evaluate the posterior probability that each healthy cell and each MC are
generated by the same source:
P
(








x | µk,Σk) (4.2)
for each healthy cell xi, where N (·) is the multivariate normal density, µk is the mean surface
marker expression for subpopulations in MC k, Σk = Σ ∀k is the shared covariance matrix,
and πk = 1/14∀k is a uniform prior over the 14 MCs.
The posterior probability (Eq. 4.1) was evaluated for each cell in the healthy samples
(∼ 3× 106 cells) using the classify function implemented in the Matlab R2013b Statistics
Toolbox. A high posterior probability for MC k indicates that cell xi falls within the pheno-
typic boundaries estimated from the observed expression of subpopulations in MC k. Cells
that were an extremely good fit1 to one MC were considered healthy cognate cells for that
MC.
Using this technique, 71–81% of each healthy sample was sufficiently similar to one MC to
be identified as a healthy cognate. Approximately 40% of each healthy sample was assigned
to MC14, consistent with the phenotype and frequency of T cells in normal bone marrow
aspirates [92]. The proportion of each sample (healthy and AML) assigned to each MC was
used to define a score that distinguished healthy from leukemic phenotypes. Specifically, for
N cells from healthy donors and M cells from AML patients, with δ(ci = k) = 1 when cell i
1i.e., P (MC = k | x = xi) > 0.99
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(4.3)
quantifies whether cells associated with MC k were more frequently observed in healthy sam-
ples than in leukemic samples. MCs for which sk > 1 were more abundant in healthy samples
relative to leukemic samples and these included MC 5, 8, 9, 10, 11, 12, and 14. Examination
of the expression patterns in these MCs revealed interpretable normal cell types: Immature B
cells (MC5), myeloid dendritic cells (MC8), erythroblasts (MC9), granulocytes (MC10), NK
cells (MC11), mature B cells (MC12), T cells (MC14). While large numbers of healthy cells
were assigned to MC13 (∼ 14% of normal marrow cells), these were outnumbered substan-
tially by counts of MC13 cells in the leukemic samples. Given the monocytic phenotype of
MC13, this is consistent with the histopathology of AML.
For the remaining MCs (1–4, 6, 7, 13), the score sk < 1 identified phenotypes that were
overrepresented in AML, indicating malignant expansions. Intriguingly, rare healthy cognate
cells were identified in each normal marrow for each of these MCs, suggesting that leukemic
phenotypes do not depart radically from cells that occur in normal hematopoiesis. The malig-
nant MCs displayed phenotypes that resembled primitive and progenitor phenotypes with a
myeloid bias. While each malignant phenotype comprised multiple patients, only MC13 con-
tained subpopulations from every patient. Occupancy in MC13 varied substantially between
patients (0.8%–77%), consistent with a model of AML as a block in myeloid differentiation
with variable severity [90].
Samples were evaluated quantitatively in terms of their proportional occupancies of the 14
MCs (Figure 4.9 C). As expected, the 5 healthy samples were similar to each other and distinct
from AML. Interestingly, MC occupancies organized the AML samples into subgroups that
were significantly correlated with other molecular biomarkers. For example, patients with core
binding factor translocation [t(8;21) or inv(16)] had large numbers of cells in MC4 and MC13,
placing them in a group enriched for this clinical annotation (P = 0.0014, hypergeometric
test). Patients with nucleophosmin mutations displayed a different phenotypic distribution—
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occupancy of MC2, MC7 and MC13—forming another distinct patient group (P = 0.0083).
Finally, the 3 patients characterized by large occupancies of MC1 were all cytogenetically
normal (P = 0.018). Taken together, each leukemia, although unique, appears to be formed
from a limited palette of possible phenotypes. Remarkably, the specific composition and
relative proportion of MCs was determined in part by genetic background, demonstrating a
genetic influence on the distribution of phenotypes observed in each patient.
4.4 Discussion
Tissues are complex populations of cells residing in phenotypically and functionally diverse
states. A key challenge is to dissect the high-dimensional structure of these complex popula-
tions into components that can be studied individually and collectively. In AML, where the
relationship between phenotypic and functional heterogeneity has been elusive, we used mass
cytometry to profile both surface and signaling features simultaneously in millions of leukemic
cells.
Using graphs of cellular phenotypes, PhenoGraph dissected each leukemic marrow into
discrete subpopulations that displayed distinctive immunophenotypic as well as functional
profiles. Representing each sample as a composition of subpopulations enabled a comprehen-
sive view of the phenotypic landscape of the entire cohort. The landscape resembled normal
myeloid development, but with aberrations resulting from malignant accumulation of cells
and neoplastic divergence from normal phenotypes. Surprisingly, the landscape of AML im-
munophenotypes was restricted to a limited variety of expression patterns. These patterns
occurred across different AML genetic subtypes, yet genetics had a detectable influence on
the phenotypic composition of each patient. These observations suggest the persistence of
developmental mechanisms that control the available repertoire of phenotypes even in the
context of genetic dysregulation associated with cancer.
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Figure 4.9: Metacluster (MC) analysis of the cohort’s phenotypic composition. (A) The
stacked bars indicate the contribution made by each patient to each MC. The blue segments
represent the proportion of healthy samples assigned to each MC by linear discriminant anal-
ysis, as described in the main text. (B) Average surface marker expression of each MC. Colors
represent expression intensity as in Figure 4.5 and elsewhere. Columns are matched with the
stacked bars of (A). (C) Intrapatient heterogeneity is represented by one horizontal bar for
each sample, in which segment lengths reflect the sample’s proportional composition. Segment
colors correspond to the MC descriptions in the legend below. Square boxes on the far right
indicate molecular biomarkers that were significantly correlated with patient composition.
Chapter 5
Data-driven functional profiling of
leukemic subpopulations
5.1 Signaling phenotypes reflect subpopulation function
Surface markers have become standard tools for clinical diagnosis and monitoring of blood
neoplasia [93]. In normal bone marrow, cell surface markers identify stem and progenitor cell
populations with distinct lineage potential and intracellular signaling behaviors [17]. However,
in AML, no surface marker phenotype has been established that consistently distinguishes the
more primitive blasts universally across patients (§1.2.2; [38, 39, 43]).
We hypothesized that intracellular signaling might be a better surrogate of the underlying
functional potential and therefore the mass cytometry panel included 14 intracellular signal-
ing markers, selected to represent pathways known to be functionally and clinically relevant
in AML—including JAK/STAT, PI3K/AKT and MAPK. Following previous work in AML
[46, 47], we supposed that not only the basal (unperturbed) activation of these pathways
matters, but also their potentiation upon exposure to biologically relevant stimuli. Cells were
therefore collected under one of 16 short-term molecular perturbations (Table 4.1), which—
at 15 minutes—trigger intracellular signaling cascades without causing significant changes to
surface marker expression.
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Because these perturbations did not alter surface marker expression and because only
surface markers were used to compute the PhenoGraph subpopulations, each subpopulation
contained cells from all perturbations. It was therefore possible to compute the effect of each
perturbation on each intracellular signaling molecule within each individual subpopulation.
With 14 intracellular markers and 16 perturbations, this allowed the computation of 224
signaling responses per subpopulation (described below, §5.1.1).
Each of these 224 signaling responses reveals a different facet of the underlying network
that controls cellular function. For each subpopulation, a concatenation of these responses
can be interpreted as a quantitative, high-dimensional signaling phenotype that represents
functional state. This phenotype is necessarily computed at the subpopulation level, meaning
it reflects the behavior of cells that display similar surface marker expression in a given patient.
However, the signaling phenotype itself contains only information about perturbation response
and therefore provides a measure of subpopulation function that is independent of surface
marker expression. We were therefore able to use the surface and signaling phenotypes as two
alternative characterizations of each subpopulation, enabling direct comparison of these two
kinds of phenotype.
5.1.1 Computing signaling phenotypes from molecular perturbation data
It has been shown in diverse biological systems that cellular response to environmental cues
is a stochastic process and that population-level changes induced by stimulation are often
mixtures of discrete single-cell responses [3, 94, 95]. In such cases, a shift in the population
average is secondary to a change in the underlying distribution of cellular and molecular
states. When data are available that record the states of individual cells, methods that
compare distributions rather than point estimates will be more sensitive and more accurate.
A simple approach to quantify signaling response would be to subtract the average in-
tensity of a phosphoprotein under stimulation from its average in the basal state. However,
this approach has key shortcomings. First, averaging collapses the rich, single-cell data into
a single point estimate and discards any variation in the response. For example, it is often
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observed that surface markers enrich but do not purify functionally relevant subpopulations.
In such cases, a functionally important response may change the shape of a distribution while
having a minimal effect on the average. Another limitation of average difference is that it
provides no measure of significance. Sample sizes inevitably vary and influence the reliability
of signaling response estimates—e.g., small samples can easily exaggerate the magnitude of a
response by random fluctuation. To address these concerns, we developed SARA (Statistical
Analysis of Response Amplitude), represented schematically in Figure 5.1.
Figure 5.1: Schematic depiction of
SARA.
SARA examines the entire single-cell distribu-
tion of phosphoprotein intensities to detect meaning-
ful changes between two conditions. Each phospho-
marker φ is treated as a random variable whose distri-
bution depends on two other observed variables: clus-
ter membership C and environmental condition Z. We
are interested in comparing two distributions:
Pb(φ | Z = b, C = c) (5.1)
Ps(φ | Z = s, C = c) (5.2)
where b denotes measurement in the unstimulated
(“basal”) condition and s denotes measurement under
a stimulated condition. In all cases, we compare basal
and stimulated distributions within the same cluster.
The quantity of interest for comparing the two distri-
butions is the cost converting one to the other, known equivalently as the Earth Mover or
Mallow’s distance [96] and for the one-dimensional case is the L1 norm between the empirical
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where Φ is a fine grid over the support of P (φ).
Because the quantities F (φ) are empirical distributions, they are vulnerable to sampling
error. Therefore, a measure of statistical significance for the EMD is introduced, based on
permutations. A null distribution is built by computing EMD for a large number (5000 in
practice) of permutations of Z. The null distribution captures the differences between Pb
and Ps due to sampling imbalances between the basal and stimulated conditions, taking into
account the shape of P (φ). The p-value is computed as the proportion of the null distribution
greater than or equal to the true EMD. Rather than impose a significance threshold, the p-
value is integrated into the final SARA score as an inverse weight that dampens the magnitude
of less significant responses.
Finally, while EMD is strictly nonnegative, stimulation response should be a signed quan-
tity reflecting induction or inhibition with respect to the basal condition. The sign is incor-
porated by comparing the centers of Pb and Ps. Random noise may cause spurious changes
in sign when the stimulation has an insignificant effect, in which case the significance penalty
will cause these values to be distributed near 0. There are cases for which incorporation of
direction is not appropriate (for example, a significant, evenly diverging response), but this
case was never observed in practice.





· (1− p) · EMD (5.4)
where E[·] is the expected value of a random variable.
To facilitate comparability across samples and signaling phenotypes, SARA scores were
converted to z-scores. The dynamic range of SARA scores varied substantially between con-
ditions. For example, the chemical perturbation pervanadate produced much more dramatic
responses than biological stimulations such as IL-3. Additionally, subtle sample-specific biases
in these dynamic ranges were noted before normalization, likely due to inevitable differences
in handling of primary human samples from day to day. Therefore, the SARA scores were
standardized within each sample and condition. Thus, each value in the signaling phenotype
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represents the relative magnitude of the response within the context of the given sample and
condition. Supporting the use of standardization, we expect that most conditions do not af-
fect every phospho-marker in every subpopulation; and indeed, SARA scores induced by each
condition had a single peak near zero. Thus, the use of z-scores enhances interpretability by
aligning the mean response with zero and highlighting the most significant responses
Figure 5.2: SARA generated 14 ×
16 = 224 signaling phenotypes for
each subpopulation across the cohort.
In summary, SARA was used to define signaling
phenotypes that, by hypothesis, could be treated as
functional analogues to surface marker subpopulation
phenotypes. SARA produced a quantitative signal-
ing response for each phosphoprotein marker under
each of the 16 stimulation conditions, resulting in a
224-dimensional signaling phenotype for each subpop-
ulation. Together, PhenoGraph and SARA distilled
high-dimensional data for 15 million cells into a single
matrix of subpopulations and their signaling pheno-
types, revealing a rich variety of signaling potential
across subpopulations (Figure 5.2).
5.1.2 Signaling phenotypes are decoupled from surface markers in leukemia
Within the healthy samples, surface and signaling phenotypes were tightly coupled, consistent
with previous reports [17, 97]. Hierarchical clustering of a curated set of progenitor- and
lineage-associated signaling features produced a complete separation of primitive (CD34+) and
mature (CD34−) cell types among the healthy samples (Figure 5.3; P = 2.0×10−52, Student’s
t test). In the leukemic samples, the same procedure produced a similar stratification of
signaling phenotypes, including a set of subpopulations that recapitulate the signaling profile
of healthy primitive cells. However, this stratification of primitive (PS) and mature (MS)
signaling had no association with CD34 expression (P = 0.83, Student’s t test; Fig. 4D).
Decoupling of surface and signaling phenotypes in the leukemic samples is consistent with
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evidence that surface markers are unreliable proxies of cellular function in AML [38, 39,
43, 97]. We therefore sought to use signaling phenotypes rather than surface phenotypes as
alternative proxies for functional state.
5.2 Transductive inference of leukemic maturity
PhenoGraph and SARA yielded two alternative representations for each subpopulation: a
16-dimensional surface phenotype, and a 224-dimensional signaling phenotype (Figure 5.4).
We asked if there was a characteristic signaling phenotype of undifferentiated healthy cells
that could act as a high-dimensional generalization of the CD34/CD38 surface phenotype,
which more faithfully captures the functional aspect of the primitive state.
Harnessing the tight coupling between surface and signaling in the healthy system, we
grounded our analysis in a characterization of healthy subpopulations. To explicitly define
the healthy cell types in the data, we used PhenoGraph to metacluster the surface phenotypes
of the 191 subpopulations from the five healthy samples, analogously to way AML MCs were
defined, as described above (§4.3.2). The analysis produced 20 healthy metaclusters (HMCs),
which generally displayed recognizable surface marker phenotypes corresponding to known cell
types, such as monocytes (HMC1) and HSPCs (HMC9). The explicit cell type assignments
enabled identification of signaling responses that were significantly associated with cell type.
Specifically, the HMC assignments formed a categorical variable that could be used to stratify
each signaling response in order to assess significance by analysis of variance (ANOVA).
A large number of signaling responses were strongly associated with cell type. Many of
these were induction responses specific to undifferentated cells, including G-CSF→pSTAT3
(Q = 6.4 × 10−42) and SCF→pAKT (Q = 1.0 × 10−9), as previously reported [97]. The 25
most significant type-associated signaling responses are given in Table 5.1. These responses
together with the surface phenotypes of the same subpopulations are shown for 4 selected cell
types in Figure 5.5.
We then asked whether signaling responses were entirely sufficient to distinguish healthy
cell types, rendering the surface phenotypes dispensable for characterizing the subpopulations.
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Figure 5.3: Surface and signaling phenotypes are decoupled in AML, compared to normal bone
marrow. Left Panel: Linkage sorting of 4 developmentally-relevant signaling responses in
the healthy samples identified patterns of primitive signaling (PS) and mature signaling (MS)
correlated with expression of CD34 and CD45, in the healthy samples. Linkage sorting of
the same signaling responses in the AML samples identified a cluster of subpopulations that
recapitulated the primitive signaling pattern, but displayed no consistent surface phenotype.
Colors as in Figure 5.4 and elsewhere. Right Panel: Box plots comparing CD34 expression
between PS and MS groups, stratified by disease status. CD34 expression was significantly
associated with primitive signaling only in the healthy samples.
Figure 5.4: Each subpopulation has two alternative phenotypes: one reflecting surface marker
expression, the other reflecting the configuration of the intracellular signaling network.
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Table 5.1: The 25 signaling repsonses most significantly associated with healthy cell type, as
determined by ANOVA. Q-values were computed using the procedure introduced by [98] and
implemented in the MATLAB R2013b Bioinformatics Toolbox.
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Figure 5.5: Four representative healthy cell types, identified by the HMC analysis. Each row
(across left and right panels) represents each cell type in each healthy sample. The left panels
display surface marker expression (which was used to name these groups). The right panels
displays SARA scores for signaling responses, in descending order of significance from left to
right as determined by ANOVA.
To test this idea, we used PhenoGraph Transductive Learning (PTL; §3.2) to classify sub-
populations based on either their surface or their signaling phenotypes. First, we conducted
testing on the 191 healthy subpopulations to see if PTL could successfully recover “held out”
cell type labels (i.e., the HMC assignments) using a graph derived from surface phenotypes.
Performance was evaluated using the cross-validated correct classification rate (CVCCR) as
follows:
1. Build a single graph of 191 vertices using k = 15
2. Providing cell type labels for 4 of 5 healthy samples to PTL, classify the cell types for
each vertex in the held-out sample
3. Compute the correct classification rate (CCR): the percentage of cells in the held-out
sample for which PTL recovers the correct HMC label
4. Repeat (1–3), each time withholding a different healthy sample; average CCR over the
repetitions to obtain the CVCCR
Considering that the graph which generated the HMC assignments is virtually identical1 to
1In this case the graphs are not absolutely identical because a weighted Euclidean distance was used, see
the next paragraph.
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the graph used by PTL, one should expect very good performance from the surface phenotype
graph and indeed the CVCCR was 99.42%. Such ideal performance might not be expected
when, instead of surface phenotypes, PTL is given the signaling phenotypes. However, per-
formance was quite good in that case, with CVCCR = 94%. Examining the results, we found
that the classification errors involved distinguishing mature lymphoid cell types for which
characteristic signaling phenotypes had not been measured. Focusing instead on the more
significant task of distinguishing immature (i.e., HSPCs, HMC9) from mature cell types, we
found that the signaling phenotypes were equivalently powerful to the surface phenotypes
(CVCCR = 99.85%).
Before proceeding, a technical note. With 224 signaling responses, the space of signaling
phenotypes is quite high-dimensional indeed and full of redundancies (which are there by
construction: every dimension reflects the same phosphoprotein as 14 other dimensions and
the same condition as 16 other dimensions [Figure 5.4]). To maximize the usefulness of the
signaling phenotypes, we used a feature reweighting strategy. Each feature (i.e., signaling
response) was reweighted by its importance for distinguishing healthy cell types, as quantified
by the ANOVA p-values discussed earlier in this section. Specifically, for subpopulations x




− log (pd)(xd − yx)2 (5.5)
was used to define the k-neighbors for the first step of graph construction. In other words,
the k-neighbor graphs were constructed in a space that emphasized the features that were
important for distinguishing cell types in the healthy samples. In the interest of comparing
performance between the surface and signaling phenotypes, the same reweighting strategy
was applied to both surface and signaling phenotypes for PTL.
Considering that signaling phenotypes were sufficient to distinguish healthy primitive cells,
we hypothesized that the functional state of AML subpopulations could be inferred by direct
analysis of their signaling phenotypes. Using the 191 healthy subpopulations as training
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Figure 5.6: Each AML subpopulation was given two alternative classifications, one according
to its surface phenotype and one according to its signaling phenotype.
data, we ran PTL on the full data set to infer maturity for each AML subpopulation (e.g.,
HSPC-like or monocyte-like). Because there were two alternative phenotypic profiles for each
subpopulation, we performed two separate classifications—once using surface phenotypes and
once using signaling phenotypes (Figure 5.6).
5.2.1 Inferred functional maturity diverges from surface phenotypes in
AML
The classifiers identified primitive subpopulations within each patient sample, reflecting the
heterogeneous nature of the samples. At the cohort level, each classifier labeled ∼ 25% of
subpopulations as primitive, but only 16% were identified as primitive by both classifiers
simultaneously (Figure 5.7). In many cases (32/99), subpopulations with primitive surface
marker phenotypes exhibited signaling that resembled mature cells. Conversely, many sub-
populations displayed primitive signaling in the absence of primitive surface marker expression
(51/118).
We denote cells labeled primitive by the surface phenotype classifier as Surface-Defined
Primitive Cells (SDPCs) and cells labeled primitive by the signaling classifier as Inferred
Functionally Primitive Cell (IFPC). For each patient, the sample proportion assigned to
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Figure 5.7: Results of the surface and sig-
naling based classifications on the t-SNE
map of Figure 4.5
Figure 5.8: Frequencies of primitive cells
in each patient as determined by the two
alternative definitions.
CHAPTER 5. DATA-DRIVEN FUNCTIONAL PROFILING 93
Figure 5.9: The data-driven estimates of primitive cells based on surface marker profiles
(%SDPC) is highly correlated with an independent estimate based on a standard immunophe-
notypic procedure for blast enumeration. This indicates that PhenoGraph clustering and
transductive learning are highly accurate while also implying that CD34 and CD45 effectively
summarize the maturity-related information of surface marker profiles.
each of these labels produced two alternative measures of maturity (%SDPC or %IFPC;
Figure 5.8). This is similar to summarizing the degree of maturation by the enumeration
of CD34+/CD45low blasts, a practice often used in the clinical diagnosis and classification
of leukemias [93]. Indeed, we found that %SDPC was highly correlated with this standard
manual gating procedure, which was performed independently (Figure 5.9; Pearson’s r =
0.96, P = 4.4×10−9). Conversely, %SDPC was only weakly correlated with %IFPC (Pearson’s
r = 0.5;P = 0.05), demonstrating that these two metrics are not redundant in AML. Instead,
examination of signaling phenotypes in AML often revealed a different degree of maturation
than was indicated by the surface phenotype. We noted that the degree of discordance between
IFPC and SDPC assignments was not constant across patients, indicating that the tendency
of IFPCs to express canonical LSC markers was itself a variable patient feature. For example,
the IFPCs in patient SJ05 were well represented by the CD34+/CD38mid phenotype (Figure
5.10, left column). In other cases, IFPCs were found exclusively in the CD34− fraction, even
when CD34+ blasts were abundant (e.g., SJ16).
Differences in signaling patterns between primitive and mature leukemic subpopulations
reveal the responses most important for these classifications. To quantify the importance
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Figure 5.10: Detailed surface and signaling phenotypes of IFPC subpopulations in 4 repre-
sentative samples. Biaxial dot plots (left) show the CD34/CD38 phenotype of IFPCs (red)
in each sample. IFPCs displayed the canonical CD34/CD38 phenotype of primitive cells in
only a subset of samples, here best exemplified by SJ05. The central panels show the place-
ment of IFPCs on the cohort landscape (Figure 4.5; IFPCs in green, non-IFPCs in maroon,
H1–H5 in gray). On the right, heat maps display the signaling and surface phenotypes of all
non-lymphoid subpopulations of each sample, stratified by IFPC classification (indicated by
green and maroon bars). Signaling responses are ordered as in Figure 5.5. Signaling responses
marked in bold with vertical lines were especially distinctive of IFPCs.
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of each signaling response, we used canonical variates analysis (CVA), a multi-class, multi-
dimensional generalization of Fisher’s linear discriminant [99]. CVA is similar to principal
components analysis (PCA) in that it seeks a linear projection of the high-dimensional data
into a low-dimensional space, but whereas PCA is unsupervised, CVA uses class labels to
find a projection that maximizes the separability of these classes in the target space. This
method allows visualization of the linear separability of the classes in low-dimensional space
and simultaneously identify the features that are important for obtaining that separability by
examining the projection matrix.
In this case, the input data were the 224-dimensional signaling phenotypes and the class
labels were binarized into IFPC and non-IFPC. CVA revealed that the linear separability of
these classes could be maximally preserved in a single dimension (Figure 5.11). The signaling
responses most important for class separability were identified as the entries of the projection
matrix with the largest (absolute) magnitudes. In this way, CVA performs feature selec-
tion implicitly. Re-running CVA with small numbers of top-ranking features produced nearly
equivalent separability. We found that that the majority of discriminative power could be at-
tributed to 5 responses: G-CSF→pSTAT3, SCF→pAKT, G-CSF→pSTAT5, FLT3L→pAKT,
and IL-10→pSTAT3. Primitive subpopulations displayed strong activation in the first four
of these responses, which have all been previously implicated in the biology of HSPCs [97,
100, 101] and in the pathobiology of AML [46, 102, 103]. Additionally, attenuation of the
IL-10→pSTAT3 response—a response exhibited by mature immune cells [104]—was also a
distinctive feature of IFPCs.
Evaluating the ability of surface markers to identify IFPCs, it was clear that no surface
phenotype could be applied universally across patients. CD34 was often an important label for
IFPCs, but only in a subset of cases. CD34 marked both primitive and mature subpopulations
in patient SJ03, where HLA-DR was a more specific marker of IFPCs (P = 0.0007 vs. P =
0.003, Student’s t test). In SJ05, where CD34 expression was tightly associated with IFPCs
(P = 7.4× 10−8), the multidimensional surface measurements revealed that CD123 was also
an important marker (P = 4.4 × 10−6), whereas CD123 did not identify IFPCs in SJ03.
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Figure 5.11: Canonical variates analysis identifies the signaling features that most effectively
separate IFPCs from non-IFPCs. Left Panel: IFPCs and non-IFPCs can be almost per-
fectly separated using the first canonical variate. Right Panel: Almost the same separability
is achieved when only the top 5 features are used to compute the projection.
Patient SJ11 lacked CD34 expression almost entirely, as expected for this nucleophosmin-
mutated case [39]. In this patient, IFPCs were distinctly labeled by elevated expression of
CD47 (P = 7.1 × 10−6) and CD123 (P = 3.4 × 10−5). Surprisingly, we found that CD34
expression can be strongly anti-correlated with primitive signaling, as in patient SJ16, where
CD34 expression was higher in mature cells (P = 0.0027) and IFPCs were marked instead by
elevated expression of CD117 (P = 0.0026).
5.3 Signaling phenotype identifies clinically prognostic gene
expression signature
Ultimately, intratumor heterogeneity is import insofar as functionally distinct subpopulations
influence clinical outcomes, especially patient survival [42]. While our mass cytometry cohort
was too small for survival analysis, genome-wide expression arrays for 15 of our 16 patients
were available from a previous study ([105] and §A.4), providing a link to larger cohorts for
which gene expression and survival data were available. Because our samples displayed a wide
range of IFPC frequencies (Figure 5.8), we reasoned that this variance could be exploited to
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identify genes whose expression covaried with these frequencies by in silico expression decon-
volution [106]. As IFPC frequency varies across samples, genes expressed specifically by these
cells should be detectably more or less abundant in the bulk gene expression measurements,
thereby providing an estimate of %IFPC in independent samples from the level of this gene
signature, measured in bulk.
5.3.1 Gene expression deconvolution
We developed a deconvolution method based on linear regression and cross-validation. The
basic assumption of in silico deconvolution is that a subpopulation of interest expresses certain
genes at constant rates; therefore changes in bulk expression measurements of these genes will
track with changes in subpopulation size. This can be formulated as the general linear model
Y = Xβ + ε (5.6)
where Y is a N ×G matrix of G mean-centered gene expression values, X is a N ×1 vector of
subpopulation frequencies (e.g., %IFPC) for N samples, and β is a 1×G vector of regression
coefficients. β can be obtained from the least squares solution and represents, for each gene,
its estimated “expression level” in the subpopulation.
Because gene expression data are noisy and our data contained arrays for only 15 pa-
tients, we developed a cross-validation scheme to reduce overfitting and spurious associations.
Specifically, we used leave-two-out cross-validation: The patients were split into 105 unique
combinations of 13 from 15 and β was solved for each of these 13-patient data subsets. For
each solution of β, genes were assigned to percentile bins. Genes were added to the signature
if they were placed in the top percentile more often than any other bin and had a standard
deviation across data subsets of less than 5 percent. The entire strategy was performed to
identify two subpopulation-associated gene signatures: an IFPC-associated set of 49 genes and
a SDPC-associated set of 42 genes (Table 5.2).2 To characterize these signatures, we queried
214 genes appeared in both signatures. These may be interesting in their own right but form too small of
a group to analyze and were generally excluded for comparisons of the other signatures.



















































Table 5.2: Gene signatures obtained from microarray deconvolution.
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Figure 5.12: The mean expression of the gene signatures identified by deconvolution are
strongly correlated with the subpopulation frequencies they are supposed to represent. This
is a necessary condition to use the signature means as proxies in other samples.
the Molecular Signatures Database [107] for annotations significantly overlapping with each.
The SDPC signature—which contained CD34 as its top-ranking gene—was highly enriched
for gene sets associated specifically with CD34+ AML (e.g., cases with the AML-ETO1 fusion
[108], Q = 7.4×10−11). Alternatively, the most significant annotation for the IFPC signature
was a set of genes upregulated in CD133+ hematopoietic stem cells [109] (Q = 5.5 × 10−8).
CD133 marks healthy stem cells that are possibly more primitive than CD34+ HSCs [110] and
has been linked to cancer stem cells in multiple cancer types [111, 112]. The mean expression
of each signature was highly correlated with its corresponding subpopulation frequency (Fig-
ure 5.12), indicating that the signature mean was an appropriate proxy for these frequencies
in independent clinical cohorts for which single-cell measurements were not available.
5.3.2 Survival analysis
The signatures were tested in two independent cohorts of adult AML for which both gene
expression and survival data were available for a total of 242 patients [113]. For Kaplan-
Meier analysis and log-rank statistics, each patient was assigned to one of two groups based
on whether its signature score (i.e., the mean expression of genes in the signature of interest)
was above or below the cohort median.
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While the SDPC signature was associated with survival in one cohort, this was not repli-
cated in the other. Alternatively, the IFPC signature was predictive of poor survival in both
cohorts (Figure 5.13). Combining the patients into one large cohort, the IFPC signature was
highly predictive of poor survival (P = 4.8×10−6, Hazard Ratio [HR] = 3.4), while the SDPC
signature formed a less significant predictor (P = 0.005, HR = 1.6). To test these signatures
against each other, we placed them together in a bivariate Cox regression model. In this
setting, the IFPC signature retained its predictive power (P = 8.2× 10−5, HR = 3.0), while
the SDPC signature became completely uninformative for survival (P = 0.29, HR = 1.2).
We also examined the relationship between the IFPC signature and three signatures re-
ported by [43], which were also developed to capture primitive gene expression programs in
AML. For each Eppert signature, we found that the reported correlations with survival in
the data of [113] were reproducible. To assess the prognostic value of the IFPC signature
when these other signatures were known, we tested three bivariate Cox regression models in
which each of the Eppert signatures was used as a predictor alongside the IFPC signature.
The IFPC signature proved to be a stronger predictor of survival than any of the Eppert
signatures. In each model, the IFPC signature retained significance (P < 0.005), while each
Eppert signature became statistically insignificant (P > 0.07). In a multivariate Cox regres-
sion model containing all signatures (IFPC, SDPC and the Eppert signatures), only the IFPC
signature retained significance (P = 0.012, HR = 2.4).
5.4 Discussion
In Chapter 4, we saw that the surface marker phenotypes of leukemic cells are restricted to
a limited set of patterns that somewhat resemble myeloid development. This resemblance
suggests that the functional maturity of leukemic cells might be reflected in their surface
marker expression patterns. In this chapter, we have shown that the apparent maturity
suggested by surface marker expression often belies a different functional state as reflected
in the underlying behavior of the cells’ signaling networks. Whereas surface and signaling
phenotypes displayed tight coregulation in normal bone marrow, this coregulation was broken
CHAPTER 5. DATA-DRIVEN FUNCTIONAL PROFILING 101
Figure 5.13: IFPC frequency identifies a gene expression signature that predicts clinical out-
come. (A) IFPC gene signature identified by deconvolution of bulk expression data. The heat
map displays expression of each gene in bulk measurements. Rows are alphabetically ordered;
columns are ordered by the mean expression of the genes in the signature. (B) The mean of
the IFPC signature forms a clinically significant prognostic indicator of overall survival in 2
independent cohorts of adult AML [113]. Patients were stratified for Kaplan-Meier analysis
by whether their IFPC expression score was below or above the cohort median.
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in AML. The substantial decoupling of surface and signaling phenotypes in the leukemic cells
renders the surface markers typically used in diagnostics unreliable proxies of cellular state
and function in AML.
Using PhenoGraph Transductive Learning (Chapter 3), we identified leukemic subpopu-
lations that displayed signaling phenotypes similar to the immature hematopoietic stem and
progenitor cells (HSPCs) of normal bone marrow. This provided a data-driven classification
of functionally primitive leukemic subpopulations irrespective of their surface phenotypes. We
found that these inferred functionally primitive cells (IFPCs) displayed signaling responses
consistent with known properties of immature hematopoietic cells, such as phosphorylation
of STAT3 on exposure to G-CSF [97].
The IFPC phenotype was found to occur in most AML samples at varying frequencies
and with variable surface phenotypes, often with low or absent CD34 expression. While
no universal surface phenotype captured IFPCs across patients, within each patient IFPCs
displayed homogeneous expression in certain markers—markers whose importance was neither
universal nor unique. Our results suggest that a subset of leukemic cells maintains a conserved,
progenitor-like signaling program that phenocopies the regulatory state of normal HSPCs,
regardless of surface marker expression and underlying genetic mutations.
Deconvolution analysis of microarray data identified a gene expression signature associated
with the IFPC phenotype that can serve as a proxy for the frequency of this phenotype
in a given sample. This gene expression signature was enriched for annotations related to
primitive hematopoietic cells and included genes—such as PROM1, SOCS2, and CD96 —–
that have been previously associated with healthy and/or leukemic stem cells [114, 115].
Importantly, this gene expression signature predicted survival in independent AML patient
cohorts, suggesting that this signaling-based definition describes a clinically relevant cellular
phenotype.
It was previously demonstrated [43] that functional characterization by physical sorting
and xenotransplantation could be used to identify genes correlated with patient survival. Our
analysis is conceptually related, but instead of differential expression between sorted cells, we
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used in silico deconvolution to identify genes, based on the measured cellular frequencies of
the IFPC phenotype. Ultimately, both approaches seek to identify primitive cells by means
that emphasize functional over surface phenotypes, and to test whether the predominance of
primitive cells–—approximated by expression of a gene signature—–is associated with poor
survival.
The signaling-based definition of primitive cells warrants further investigation as it may
indicate pathways that influence the maturation of leukemic cells and could be leveraged
therapeutically to block survival or direct differentiation. More broadly, this molecular inter-
rogation approach could be used to characterize primitive cells in any cancer where a cognate




Single-cell analysis has resumed the spotlight in biological science owing to technological de-
velopments that allow these primary units of the organism to be measured with high enough
dimensionality that their true phenotypic and functional diversity is revealed. In particular,
this dissertation has explored the diversity of cell states revealed by mass cytometry. Mass
cytometry is capable of measuring dozens of protein features per cell, including phosphoryla-
tion of intracellular signaling molecules, and allows barcoded multiplexing of cells measured
under different molecular perturbations. This experimental design produces complex data
that benefit from computational methods, which integrate and extract knowledge from them.
Experimental approaches to immunophenotyping have hit an analytical ceiling because
they rely on the predictability of the underlying system that cannot always be assumed—
especially in disease states such as cancer, where molecular deregulation can cause different
cell states to emerge from patient to patient. In leukemia, a particularly important cell
state—the leukemic stem cell—has been shown to exist in most patients, yet it is known
to display different immunophenotypes in different patients. This presents a challenge that
experimental approaches which require prospective gate definitions, like FACS, are ill-equipped
to deal with. In this dissertation, data-driven computational approaches present a fruitful
alternative direction. By assuming less about the cancer samples, more can be learned.
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To take a data-driven approach, we begin by modeling each sample as a composition
of subpopulations. Subpopulations are defined algorithmically, based on quantitative high-
dimensional measurements, rather than prospective gating based on assumptions from knowl-
edge of normal hematopoiesis. The algorithm is motivated by a theoretical construct rep-
resenting the process that generates a multicellular population—the phenotypic manifold.
Taking insights from topology, we develop an approximation of the phenotypic manifold that
is based on a graph. The graph models the cellular population by modeling connectivity
between cells, which reflect phenotypic similarity. Reasoning that stable cellular states will
result in regions of high local density, we equate densely interconnected subgraphs with bi-
ologically meaningful subpopulations. Borrowing from network analysis, we use the concept
of modularity to partition the graph into densely interconnected subgraphs, revealing the
biologically meaningful subpopulations. This method was given the designation PhenoGraph
(Chapter 2).
Applying PhenoGraph to an AML cohort established that each patient’s leukemic blasts
occupied multiple phenotypic states. Surprisingly, these states fell into a restricted set of
expression patterns that resembled myeloid development. As the number of dimensions in-
creases, the number of possible marker combinations increases geometrically—if the markers
are independent. Instead we found that the number of leukemic states was less than the mod-
est number of patients in our cohort, suggesting that strong constraints on the phenotypic
landscape of AML blasts persist after disease initiation. Interestingly, the distribution of each
patient into these limited expression patterns was significantly associated with some genomic
biomarkers, indicating a genetic influence on the subpopulation structure of leukemia.
A majority of leukemias contained blast subpopulations that resembled less and more
differentiated myeloid cell types, suggesting a developmental continuum present in each pa-
tient. This is consistent with other evidence that AML is a disease caused by dysfunctional
myelopoiesis. However, while many of the blast subpopulations displayed immunophenotypes
resembling normal hematopoeitic stem and progenitor cells (HSPCs), it is also known that
leukemic stem cells do not always display this phenotype. We therefore undertook an inde-
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pendent functional characterization of each subpopulation based on molecular perturbation
data.
Most functional assays, such as colony formation or xenotransplantation, require prospec-
tive isolation of cells by FACS prior to functional characterization. We took an alterna-
tive, in silico approach to functional characterization, which was compatible with the high-
dimensional, data-driven method used for identifying subpopulations. To functionally charac-
terize each subpopulation, we made use of the short-term molecular perturbations, which—at
the order of 15 minutes—trigger intracellular signaling cascades without causing significant
changes to surface marker expression. Therefore, because subpopulations were defined using
only surface markers, each subpopulation contained cells exposed to one of 17 distinct envi-
ronmental conditions. Making the assumption that the responsiveness of signaling cascades
to these biologically relevant perturbations (e.g., G-CSF) reflects the regulatory state of the
intracellular machinery that controls cell function, we took these perturbation data as a start-
ing point for functional characterization. Quantifying the change in phosphorylation of each
signaling protein caused by each perturbation resulted in 14 (intracellular markers) × 16 (17
- 1 for the basal condition) = 224 signaling responses per subpopulation. Thus, in addition to
its 16-dimensional surface marker profile, each subpopulation had a 224-dimensional signaling
profile that reflects the regulatory state of cells it contains.
To interpret these two sets of phenotypes, we integrated knowledge from normal hematopoiesis.
All analyses described above were also applied to our 5 normal bone marrow controls. As
expected, each normal bone marrow was partitioned into virtually identical compositions of
distinct subpopulations, reflecting the regulatory precision and predictability of healthy tis-
sues. It was straightforward to interpret the healthy subpopulations and identify them as
various lymphoid, myeloid, or progenitor cell types. These labels made it possible to set
up a transductive learning problem (Chapter 3) in order to categorize the leukemic subpop-
ulations according to their phenotypic or functional relatedness to the healthy cell types.
This approach allowed inference from features of healthy progenitors to features of leukemic
subpopulations in the high-dimensional measurement spaces of either surface or signaling
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phenotypes—a quantitative extension of previous attempts to infer leukemic maturity from
the expression of one or two markers (CD34 and CD38).
As expected, transductive learning from surface phenotypes yielded results very similar
to manual gating based on CD34. On the other hand, transductive learning from signaling
phenotypes yielded results that sometimes varied substantially from the predictions based
on surface phenotypes. Leukemic subpopulations that look like HPSCs on the surface do
not always display HSPC-like signaling, and leukemic subpopulations that display HSPC-like
signaling do not always look like HSPCs on the surface. Whereas the percentage of cells
with a surface marker profile resembling HSPCs (%SDPC, surface-defined primitive cells)
yields a more “conventional” characterization of leukemic maturity (similar to %CD34+),
the percent displaying HSPC-like signaling (%IFPC, inferred functionally primitive cells)
provided an alternative estimate of the frequency of functionally undifferentiated cells. In
other words, these characterizations might be taken as alternative estimates of the severity of
the differentiation block for each patient.
It has been previously shown that the estimated frequency of immature leukemic blasts
is correlated with clinical variates such as overall survival. We therefore undertook similar
analyses to test whether %IFPC or %SDPC were significantly associated with survival. Be-
cause the primary mass cytometry cohort was too small for survival analysis, we developed a
bridge to test these features in larger cohorts. Because bulk gene expression (i.e., microarray)
data were available for the samples in the primary cohort, we were able to extract sets of
genes, via in silico gene expression deconvolution, that were highly correlated with either
%IFPC or %SDPC across the primary cohort. Gene set enrichment analysis supported the
hypothesis that these genes were actually expressed in the IFPC or SDPC states. We there-
fore hypothesized that other patients with high frequencies of IFPCs or SDPCs should have
detectably higher expression in these respective gene sets if their marrow is also subjected
to bulk expression measurement. Using two independent cohorts, we found that the IFPC
signature in particular was significantly predictive of overall survival in AML patients.
The analyses presented here represent a large-scale, data-driven, quantitative and mul-
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tivariate study of cellular phenotypes in healthy and diseased tissues. In possessing these
qualities, the work can be considered an answer to the call for a new brand of quantitative
cell biology that utilizes the advantages of computational inference [1]. We have demonstrated
the power of data-driven techniques for identifying diverse cell states and learning about their
features. In particular, we have shown that the phenotypic composition of human acute
myeloid leukemias is diverse but restricted to a palette of progenitor- and myeloid-like phe-
notypes whose frequencies are influenced by genetic background. Our data-driven analysis of
subpopulation function demonstrates that phenotypic diversity can indicate functional diver-
sity but in ways that are unpredictable across patients, a finding that has broader implications
for studies of cancer stem cells and intra-tumor heterogeneity.
6.2 Contributions of this work
Computational biology was initially inspired by the emergence of genome wide measurement
technologies. As those technologies are emerging at single-cell resolution, other methods which
measure protein expression at single-cell resolution have reached sufficiently high dimension-
ality that they can need computational methods, too.
Phenotypic heterogeneity in cancer is a popular research topic, and rightly so. To our
knowledge, few efforts have been made to approach this problem from a computational per-
spective, yet the subject is ripe for the benefits this brings. Precisely because cancer is
unpredictable, efforts to understand phenotypic heterogeneity using the apparatus of con-
ventional immunophenotyping have been stifled by inconclusive results. On the other hand,
computational methods that can discover the known population structure of normal tissues
such as bone marrow ab initio are ideal for studying the composition of tumor samples as
they can recapitulate the efforts of decades of experimental research in the context of a single
sample. Thus, the potential uniqueness of a cancer sample is met by an approach that is
indifferent to that feature which is so problematic for prospective approaches.
The idea of identifying subpopulations computationally in single-cell data is not itself
novel, but rather suggests itself naturally to many who have worked with this type of data.
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A number of methods have been developed to this end, especially in recent years. Unfor-
tunately, we found that these methods did not deliver quality results at the scale of mass
cytometry data, in terms of both cell count and dimensionality. We believe it is vital to
accommodate current and future scaling up of single-cell measurements and to do so without
sacrificing quality. With the concurrent aims of scale and quality in mind, we developed a
novel approach that extracts subpopulation structure using a graph-based representation of
phenotypes. The use of the graph is conceptually motivated and handles features of single-cell
data that thwart other methods, such as non-linear relationships between protein expression
and subpopulations that form arbitrary non-convex shapes in high-dimensional space. The
graph-based implementation also provides access to computationally efficient techniques which
can accommodate very large samples without resorting to subsampling, which substantially
improves the robustness of the results.
The work presented here does not simply aim to show that phenotypic heterogeneity exists,
but rather takes it as a starting point for several further analyses. To our knowledge, no
previous work presents a quantitative comparison of intratumor heterogeneity across multiple
cancer samples. The resulting cohort landscape simultaneously demonstrates not only that
intratumor heterogeneity is widespread, but how the subpopulations of different individuals
relate to each other. The landscape shows that patients can differ both in the phenotypes
that occur and in the frequencies with which they occur. The complementary metacluster
analysis showed that these frequencies are influenced by the patient’s genetic background.
This demonstrates that a genetic lesion need not produce a single malignant phenotype but
may cause a particular distribution of phenotypes, highlighting the interplay between genetic
and epigenetic mechanisms in generating intratumor heterogeneity.
The computational analysis of subpopulation function provided new insights to the contro-
versial relationship between phenotypic and functional heterogeneity. The in silico functional
estimates were computed for each of ∼ 30 subpopulations per leukemic sample, represent-
ing an order of magnitude higher resolution than can be achieved by FACS gating, which
furthermore suffers from the prospective gating requirement as mentioned several times pre-
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viously. At this level of resolution, it was clear that functionally primitive subpopulations
often but far from universally express CD34. Similarly, many CD34+ subpopulations did
not display a functional profile similar to HSPCs. Even at 16 dimensions, no universal pat-
tern of surface marker expression identified functionally primitive subpopulations. On the
other hand, the signaling profile itself presented a high-dimensional pattern that more closely
reflects the maturation of leukemic subpopulations, supported by the gene expression and
survival analyses. The discriminative power of these signaling patterns could largely be at-
tributed to 5 features: G-CSF→pSTAT3, SCF→pAKT, G-CSF→pSTAT5, FLT3L→pAKT,
and IL-10→pSTAT3. Compared to the various observed surface marker patterns, a definition
of functional maturity based on these signaling features is more universal across patients.
From a methodological perspective, PhenoGraph is a novel technique for learning cell
states from data, which displays unprecedented accuracy and computational efficiency. Its
accuracy is attributable to its representation of cellular phenotypes as a graph that approxi-
mates an underlying phenotypic manifold. By operating on neighborhoods instead of distances
themselves, the Jaccard graph encodes the connectivity between points together with their
local density, which enhances edges within continuous structures and penalizes edges that
span sparse or noisy regions. The quality of PhenoGraph’s results can also be attributed to
the selection of modularity as an appropriate objective function for density detection in the
Jaccard graph. The efficiency can be attributed to parallelization of nearest-neighbor com-
putations as well as to the availability of modularity optimization routines that are designed
for large-scale social network analysis.
In this dissertation, PhenoGraph was introduced together with a demonstration of its
utility for investigating the pathophysiology of a particular cancer—acute myeloid leukemia.
PhenoGraph is general and scalable both in terms of dimensionality and sample size, making
it suitable in a wide range of settings for which single-cell population structure is of inter-
est, including other cancers or healthy tissues, and for use with other emerging single-cell
technologies such as single-cell RNA-seq. Many such cases are presented by the tumor mi-
croenvironment, including drug-resistant tumor subpopulations, infiltrating immune cells, and
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reactive stromal components. PhenoGraph is also applicable to healthy tissues, within which
a large diversity of cell types remains uncharted.
6.3 Future directions
PhenoGraph addresses probably the most fundamental question posed by single-cell data:
What are the subpopulations present in the sample? In this dissertation, PhenoGraph an-
swered this question in the context of normal and malignant bone marrow. PhenoGraph
requires only the simplest experimental design: Measure cells. Given nothing but these mea-
surements, PhenoGraph extracts groups of phenotypically coherent subpopulations. Because
PhenoGraph does not consider additional “metadata”—such as condition or time point—it
(and in fact any clustering method) is an unsupervised learning technique. On the other hand,
the PhenoGraph Transductive Learning (PTL) algorithm takes a more structured data set,
in which metadata are available—in the form of class labels—for a subset of measurements.
An algorithm like PTL, which extends information from known to unknown observations, is
a semi-supervised learning technique. PhenoGraph and PTL use the same underlying data
model—a graph of phenotypes—yet they operate on that model differently in order to answer
different kinds of questions.
Indeed, the graph-based representation of phenotypes is a powerful and flexible approach
to single-cell data, which can be deployed in different ways to target different experimental
questions. For example, in previous work our group used graphs to model cellular differ-
entiation as a continuum of transitional states, a method called Wanderlust [53]. While
PhenoGraph analyzes the density structure of the graph, Wanderlust and PTL consider a
dynamic process on the graph: a random walk.
As we saw in Chapter 3, graphs possess a deep connection to probabilistic potential theory
and, as we explore presently, to the general mathematical framework of Markov chains. The
graphs used in Wanderlust, PhenoGraph, and PTL are only a simple matrix operation away
from explicitly representing a Markov chain. When this connection is made, powerful analytic
tools developed for Markov chains become available for the analysis of single-cell data.
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Consider the weight matrix W, discussed in Chapters 2 & 3 (e.g., §2.2.1), in which the
entry Wij represents the phenotypic similarity between cells i and j. Drawing again on the
phenotypic manifold concept (§1.3.4), we might assume that phenotypic similarity implies a
dynamical relationship—specifically, if cell j is similar to cell i it is likely that j is derived from
i or was recently in a state identical to i. This relationship can be formalized as a transition
probability:
P (Xt+1 = j | Xt = i) (6.1)
where X is a random variable representing the phenotype of the cell at an arbitrary time t.1
Intuitively, if i and j are phenotypically very similar, then there is a strong dynamic coupling
between them: A cell in state i is likely to move to j and the transition probability (Eq. 6.1)
is high.
It is reasonable to assume that transition probabilities obey the first-order Markov prop-
erty, i.e., that transitions depend only on the current state, not on a previous state k:
P (Xt+1 = j | Xt = i) = P (Xt+1 = j | Xt = i,Xt−1 = k) (6.2)
and so on for states prior to k.
All entries of W are strictly nonnegative. If the rows of W are normalized such that they
sum to 1, then each row wi can be interpreted as a vector expressing the probability (Eq.
6.2) that a cell with phenotype Xi at time t moves to phenotype Xj at t+ 1, for all j. Thus,
the right stochastic matrix:
M = D−1W (6.3)
with D = diag(deg(v1), . . . ,deg(vN )) (as in §3.2) is easily obtained from the weight matrix of
the graph and can be subjected to numerical techniques in order to learn about the underlying
cellular system.
The power of the Markov chain formalism can be illustrated with a simple example. While
1Here, “time” is an index of the discrete dynamical process, not a measured value as in a time course
experiment.
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PhenoGraph is designed to identify cells that are most similar, an alternative experimental
design may seek to identify cells that are most different from each other. For example, suppose
two samples are collected before and after a treatment, and the objective is to identify cells
that are induced by the treatment—in other words, phenotypes that are specific to the post-
treatment sample. This question can be answered in the Markov chain framework using a
quantity known as the hitting time, Hij , the expected number of steps a random walker
starting at i takes before reaching j, averaged over all possible random walks emanating
from i. Let A denote the set of pre-treatment cells and B the set of post-treatment cells.
Consider one cell, β ∈ B and the hitting times from all other cells to β. If β is unlike most
pre-treatment cells then it will take a long time for random walks beginning at a ∈ A to
reach β—the hitting times from A will be large compared to the hitting times from B. Thus
the divergence between the two hitting time distributions, HAβ and HBβ , would quantify the
specificity of β to the post-treatment sample. As hitting times can be computed from spectral
analysis of M (Eq. 6.3) [116], placing the problem in the context of Markov chains provides
a mathematical framework for extending the graph-based representation of phenotypes to
answer new questions.
The approaches presented in this dissertation, which build and operate on graphs of phe-
notypes, can be seen as particular instances of this more general framework. The recognition
of this framework is important as it provides foundations from which other extensions and
specializations can be derived, suggesting a way forward for future projects in computational
cell biology.
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Twenty (20) deidentified diagnosis bone marrow mononuclear cell (BMMC) specimens, se-
lected to span a variety of different AML subtypes, were obtained from the tissue bank at
St. Jude Children’s Hospital (Memphis, TN). These samples had been analyzed for genome-
wide gene expression and copy number alteration, as well as mutation status in a small set
of putative oncogenes [105]. Sixteen (16) samples were included in the final pediatric AML
cohort: Three samples were excluded due to insufficient cell number and one was excluded
because signal from internal standard beads (see §A.3, below) did not pass quality control
(QC) thresholds. The final pediatric AML cohort was 50% male with a mean age of 10.4
years. The final cohort reflected much of the interpatient heterogeneity observed in pediatric
AML, and included samples with t(8;21) chromosomal translocations, inv(16) inversion, MLL
rearrangements, as well as cytogenetically normal samples. Samples were classified by the
French-American-British (FAB) system as M1, M2, M4, or M5, and thus reflected a broad
range of histopathological categories. For all healthy adult controls, deidentified cryopreserved
healthy BMMC samples were purchased from AllCells, Inc. (Emeryville, CA). The healthy
adult cohort for signaling studies (n = 5, sample IDs: H1–H5) ranged in age from 19–28 years
with a mean of 23.4 years. Nine deidentified adult AML BMMC specimens were obtained
from Princess Margaret Hospital (Toronto, ON) and included in surface marker selection ex-




A.2 Design of hybrid antibody panel
A.2.1 Antibodies
Purified monoclonal antibodies were obtained from commercial vendors and labeled with
stable metal isotopes using the MAXPARTM X8 chelating polymer kit (Fluidigm Corporation,
South San Francisco, CA) following the manufacturer’s instructions (Table A.1). Anti-cleaved
caspase-3 was measured but was omitted from downstream analysis because we instead relied
on cisplatin viability staining to exclude dead cells [117]. The final data set included a total
of 30 antibodies against 14 intracellular targets and 16 cell-surface targets.
A.2.2 A minimal set of surface markers to capture AML heterogeneity
We sought an efficient surface marker panel of approximately 16 markers to achieve segregation
of the main subsets in the AML samples, thus freeing 15 analysis channels for simultaneous
measurement of intracellular epitopes. To address this, we performed an initial surface-only
phenotyping experiment on a panel of 32 AML samples (9 adult and 23 pediatric, including
the 16 pediatric AML samples included in the final cohort). Each sample was stained with
two overlapping surface marker panels of 31 antibodies each (42 unique antibodies in total,
(Table A.2). We designed a simple feature-scoring algorithm based on principal component
analysis (PCA) to identify the non-redundant markers in each patient while capturing the
overall diversity across the patients. It consisted of the following steps:
1. Events were gated to remove doublets (DNAhigh/event lengthhigh) and non-nucleated
cells or debris (CD45−/DNAlow)
2. PCA was performed on single-cell data from each patient individually





|coeff(c)| × λ(c) (A.4)
where coeff(c) is the coefficient of marker M in component c and λ(c) is the eigenvalue
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Label Target Clone (Vendor) Staining conc.
141 Pr PLCg2 (pY759) K86-689.37 (BD) 1
142 Nd CD19 HIB19 (BD) 2
143 Nd 4EBP1 (pT37/46) 236B4 (CST) 3
144 Nd CD11b ICRF44 (BL) 4
145 Nd AMPK (pT172) 40H9 (CST) 3
146 Nd STAT3 (pY705) 4 (BD) 2
147 Sm S6 (pS235/pS236) N7-548 (BD) 1
148 Nd CD34 8G12 (BD) 2
149 Sm CREB (pS133) 87G3 (CST) 1
150 Nd STAT5 (pY694) 47 (BD) 2
151 Eu CD123 9F5 (BD) 1.5
152 Sm c-CBL (pY700) 47/c-Cbl (BD) 1
153 Eu STAT1 (pY701) 4a (BD) 1
154 Sm CD45 HI30 (BL) 2
156 Gd ZAP70/SYK (pY319/pY352) 17a (BD) 0.75
158 Gd CD33 WM53 (BL) 1
159 Tb AKT (pS473) D9E (CST) 2
160 Gd CD47 B6H12 (BD) 0.75
162 Dy CD7 M-T701 (BD) 0.5
164 Dy CD15 W6D3 (BL) 0.5
165 Ho RB (pS807/pS811) J112-906 (BD) 0.4
166 Er CD44 G44-26 (BD) 0.15
167 Er CD38 HIT2 (BL) 1
168 Er ERK1/2 (p44/42) (pT202/pY204 ) 20A (BD) 1
169 Tm P38 (pT180/ pY182) 36/p38 (BD) 0.5
170 Er CD3 UCHT1 (BL) 0.75
171 Yb CD117 104D2 (BL) 0.5
172 Yb Caspase-3 (active) C92-605 (BD) 0.5
174 Yb HLA-DR L243 (BL) 1
175 Lu CD41 HIP8 (BL) 0.2
176 Yb CD64 10.1 (BL) 2
Table A.1: Mass cytometry staining panel used for main experiments. BL: Biolegend; BD:
BD Bioscences; CST: Cell Signaling Technologies. Staining concentration is given in µg/mL.
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of component c. The score considers the first C principal components, in descending
order of λ(c).
The NRS was calculated for each of the 42 surface markers in the 36 bone marrow samples
using the first 3 principal components (Table A.2). The 16 top-scoring markers were selected
for carrying forward to future experiments, with the exception of CD2 and CD11c, which
were manually excluded on the basis that they are expressed on mature lymphocytes and
monocytes, respectively, and therefore not likely to be essential for discriminating AML blast
subsets. Two surface markers were manually selected for inclusion in future experiments,
despite the fact that they did not appear in the top 16 scores—CD117 and CD19. These
were selected based on the following rationale: CD117 is a hematopoietic progenitor marker,
and CD19 is a marker of B cells, which were otherwise difficult to identify using only the
top-scoring markers. The final set of 16 markers carried forward for future experiments was:
CD3, CD7, CD11b, CD15, CD19, CD33, CD34, CD38, CD41, CD44, CD45, CD64, CD47,
CD117, CD123, and HLA-DR.
A.3 Mass cytometry data collection and preprocessing
The protocols for surface and intracellular antibody staining, ex vivo molecular stimulation,
and cell barcoding are described elsewhere [20, 84].
Mass cytometry data were acquired on the CyTOFTM mass cytometer as previously de-
scribed [17]. Raw mass cytometry data was extracted into listmode FCS files using CyTOF
Instrument Control Software version 5.1.451 (DVS Sciences, Sunnyvale, CA) using default pa-
rameters except for the following: The instrument dual-count slopes were recalibrated weekly
using solution-based standards and “Instrument” dual-count calibration was used for FCS file
extraction; cell events with event length values between 10 and 65 were extracted.
Machine sensitivity was monitored using polystyrene internal standard beads contain-
ing 5 embedded lanthanide elements (139La, 141Pr, 159Tm, 169Tb, 175Lu) (a gift from
Scott Tanner, University of Toronto). Beads were spiked into the cell suspension immedi-
ately before measurement at approximately 2x104 beads/mL. To facilitate quantitative com-
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Rank Target NRS1 NRS2 Max. NRS Included in hybrid panel?
1 HLA-DR 22.5 20.5 22.5 Yes (high score)
2 CD34 19.3 21.4 21.4 Yes (high score)
3 CD64 – 17.0 17.0 Yes (high score)
4 CD44 15.6 16.7 16.7 Yes (high score)
5 CD15 16.5 15.5 16.5 Yes (high score)
6 CD33 15.8 15.6 15.8 Yes (high score)
7 CD45 13.7 14.5 14.5 Yes (high score)
8 CD38 14.1 11.2 14.1 Yes (high score)
9 CD11b 13.2 – 13.2 Yes (high score)
10 CD3 13.1 12.9 13.1 Yes (high score)
11 CD7 12.9 12.4 12.9 Yes (high score)
12 CD41 12.3 – 12.3 Yes (high score)
13 CD2 – 12.2 12.2 No (T / NK marker)
14 CD123 11.8 10.5 11.8 Yes (high score)
15 CD11c 11.7 – 11.7 No (monocyte marker)
16 CD47 10.6 10.3 10.6 Yes (high score)
17 CD8 10.4 – 10.4 No (low score)
18 CD49d – 10.1 10.1 No (low score)
19 CD117 9.7 9.7 9.7 Yes (HSPC marker)
20 CD14 9.6 7.9 9.6 No (low score)
21 CD5 – 9.1 9.1 No (low score)
22 CD45RA 8.3 6.6 8.3 No (low score)
23 CD4 8.1 – 8.1 No (low score)
24 CD16 8.0 5.7 8.0 No (low score)
25 CD13 6.9 – 6.9 No (low score)
26 CD61 6.6 – 6.6 No (low score)
27 CD184 (CXCR4) 6.6 5.7 6.6 No (low score)
28 CD133 – 6.1 6.1 No (low score)
29 CD235a/b 6.0 – 6.0 No (low score)
30 CD22 – 5.6 5.6 No (low score)
31 CD135 (Flt3) – 4.8 4.8 No (low score)
32 CD20 4.5 3.4 4.5 No (low score)
33 CD19 3.1 4.5 4.5 Yes (B cell marker)
34 IgM 4.2 – 4.2 No (low score)
35 CD161 3.9 – 3.9 No (low score)
36 TIM3 – 3.9 3.9 No (low score)
37 CD10 3.9 – 3.9 No (low score)
38 IgD – 3.6 3.6 No (low score)
39 CD90 3.5 2.0 3.5 No (low score)
40 CD114 – 3.4 3.4 No (low score)
41 CD56 2.5 2.4 2.5 No (low score)
42 CD79b – 2.1 2.1 No (low score)
Table A.2: Antibodies included in two pilot studies to determine a minimal set of informative
markers for use in the hybrid panel. The NRS (Eq. 3) was calculated for each marker and
averaged over the 36 bone marrow samples used for this pilot study. NRS1 and NRS2 refer
to the two overlapping panels.
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parisons between data acquired on different days, single-cell data was normalized as pre-
viously described [19]. Bead-normalized data are publicly available for download at http:
//cytobank.org/nolanlab/reports.
Bead-normalized single-cell measurement intensities were transformed using the hyperbolic
inverse sine with cofactor 5, as previously described [17]. To remove dead cells and debris, cells
were gated based on event length, nucleic acid staining, and cisplatin as described previously
[117].
For analysis of the surface markers we performed further normalization to: (1) Facilitate
comparison between patients, as these were each collected in a different tube; (2) Better
equalize the contribution of each surface protein to the clustering and dimension reduction
solutions. Different antibodies have varied dynamic ranges that do not necessarily reflect the
physical dynamic range or the marker’s importance and markers with larger dynamic range
can have a disproportionate influence on the clustering solution. Therefore we chose to rescale
marker intensities across the surface panel.
As proteins can be highly overexpressed in cancer, and this overexpression is often of
biological significance, we used the healthy bone marrow samples in our data as the standard
for normalization. For each surface marker, the maximum intensity observed in healthy
samples was determined as the 99.5th percentile of the 3 × 106 healthy bone marrow cells
from the 5 donors. The top half percentile was excluded from this determination because
mass cytometry data can have high-intensity outliers. Data from all samples (healthy and
AML) were divided by these psuedo-maximum values, yielding expression values that can be
interpreted as x-fold of the maximum expression observed in healthy. As a result, intensity
values for different antibodies were placed in more commensurate dynamic ranges (largely
falling between 0 and 1), and expression in AML samples exceeding 1 can be considered as
fold-change above the maximum expression observed in normal bone marrow. Because only
surface marker intensities were directly compared across samples, only these channels were
normalized in this manner.
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A.4 Microarray data and normalization
Matched gene expression profiles for our AML patients [105] were downloaded from the Gene
Expression Omnibus (GEO; ID # GSE14471). This data consisted of gene expression mea-
sured with Affymetrix U133A arrays. Gene expression and survival data for 242 cytogeneti-
cally normal adult AML patients from two independent cohorts [113] were downloaded from
GEO (ID # GSE12417). This data set consisted of arrays from two different Affymetrix
platforms (U133A and U133 Plus 2.0).
All microarray data were processed and normalized as described previously [118]. Of the
19291 probe sets on these arrays, 7604 were removed for low intensity (defined as being below
7 on log2 scale in at least 12 of the 16 arrays). Probe sets targeting the same gene whose
measurements were well correlated (r > .75) were averaged to produce consensus expression
values for 8196 unique genes. Additionally, 286 genes from the X and Y chromosomes were
excluded. Each array was normalized by dividing the log2 intensities by the third quartile
of the array. Principal component analysis of the arrays before filtering or normalization
identified the array for patient SJ12 as an outlier; this patient was excluded from all gene
expression analyses.
